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Chapter I 
 
Introduction 
Nano-particles for therapeutic applications 
Currently, the efficiency of existing and newly-developed therapeutics is often hampered 
by the absence of a proper biodistribution because they rely on non-targeted compounds.  
Packaging of drugs into targeted nanoparticles seems an obvious concept for 
accomplishing improvement of overall therapeutic efficacy, quality of life (by diminishing 
undesirable side effects) and reduction of health care costs. Indeed targeting is more easily 
amenable to nanoparticles than to drugs. Moreover, the use of nanoparticles could solve 
additional problems of many potent drugs, including: (i) poor aqueous solubility, (ii) 
optimization of drug combinations, and (iii) unfavorable pharmacokinetic behavior, which 
may result in severe toxicity due to the need of using relative high concentrations of drugs 
in order to achieve efficacy.  
Over the past two decades, rapid progress has been made in comprehending the  
recognition processes and molecular interactions that govern and control the assembly of 
supramolecular systems. This knowledge, in turn, has greatly facilitated the engineering of 
devices and systems at the nanoscale level with fundamentally new physical, chemical and 
biological properties, functions and applications, due to their nanoscale size and large 
surface area. A number of these nanodevices or nanoparticles have been applied in 
medicine, particularly within the field of oncology
1
, to solve the inadequacies of most 
therapeutic agents to reach the desired targets with marginal or no collateral damage. 
Nanoparticles should be designed in order to be able to (i) retain their cargo (drugs and/or 
contrast agents), (ii) evade the immunological surveilling system following systemic 
administration, (iii) reach selectively the diseased site (targeting), (iv) bypass extra- and 
intracellular barriers, and (v) release their cargo at the target site. 
The first nanoparticles that reached health-care fruition, and are still the object of a wide 
interest, were liposomes, initially composed of pure phospholipids and more recently also 
consisting of cationic lipids with or without phospholipids. They are the archetypal, 
simplest form of nanoparticle for drug delivery. Next to liposome-based nanoparticles, 
                                                 
1 Ferrari M. et al. 2005, Nature Reviews, 5,161 
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other typologies have entered the field of nanomedicine, each with different strengths and 
weaknesses. The most frequently applied are listed below:  
-Polymeric nanoparticles, are prepared from polymers and can be obtained either in the 
form of vesicular systems (a cavity surrounded by a polymer membrane), or nanospheres 
(matrix systems where the polymer is homogeneously distributed in a linear or branched 
fashion). In spite of the development of various synthetic and semi synthetic polymers, 
natural polymers still benefit from a large popularity in nanomedicine application.  
-Dendrimers are perfectly monodisperse polymers with a highly branched three-
dimensional architecture that confers them into a spherical shape. 
-Gold nanoshells are nanoclusters of gold atoms (1.5-2.0 nm in size) stabilized by a 
protective layer of organic molecules
2
. These systems are endowed of specific properties 
either in relation to the gold core or the organic monolayer.  
-Magnetic nanoparticles comprise an inorganic magnetic core and a biocompatible surface 
coating, for example, polymers (e.g. dextran or proteins) or amphiphilic molecules (e.g. 
fatty acids or phospholipids), that provide stability and functionality under physiological 
conditions. More complex modifications include specific targeting ligands, dyes or 
therapeutic agents
3
. 
 -Semiconductor nanoparticles comprise highly luminescent quantum dot 
cadmium/selenium cores differently coated. Although questions about their potential 
cytotoxicity has been raised, quantum dots are attractive alternatives to fluorescent dyes for 
ultrasensitive biological detection when covalently coupled to biomolecules due to their 
bright fluorescence, narrow emission, broad UV excitation, and high photostability. 
-Silica nanoparticles are synthesized by reacting tetraethyl orthosilicate with a template 
made of micellar rods. The result is a collection of nano-sized spheres or rods that are 
filled with a regular arrangement of pores whose size and geometry can be tuned by 
differential doping. The large surface area of the pores allows the particles to be filled with 
a drug to be delivered to cells via endocytosis. Careful sizing of the silica nanoparticles can 
be accomplished by osmotic procedures. 
-Carbon nanotubes are formed of coaxial graphite sheets rolled up into cylinders. These 
structures can be obtained either as single- (one graphite sheet) or multi-walled nanotubes 
(several concentric graphite sheets). Aqueous dispersions of functionalized carbon 
                                                 
2 Daniel C. et al. Chem. Rev., 2004, 104, 293  
3 Pankhurst Q. A. et al. J. Phys. D: Appl. Phys., 2009, 42, 224001; McCarthy J.R. et al. Adv. Drug Deliv. 
Rev., 2008,60, 1241 
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nanotubes (CNTs) are widely investigated for biomedical applications, such as drug 
delivery, gene delivery, or cellular/in vivo imaging and tissue-repair scaffolds
4
. 
The simplest nanoparticles (first generation) target the diseased site by passive 
mechanisms, such as extravasation through gaps in tumour neovasculature combined with 
a small size (50-100 nm) and prolonged circulation time provided by a stealth layer (for 
example, polyethylene glycol) that prevents their premature uptake by phagocytes. Surface 
charge and morphology are other features that might convey specificity towards certain 
targets.  
In more sophisticated nanoparticles (second generation) additional functionalities allow for 
molecular recognition of the target tissue or for active or triggered release of nanoparticle 
cargo. Therefore, antibodies, ligands, aptamers, and small peptides that bind to specific 
target-cell surface markers, expressed at the diseased or target site, have been used as 
targeting moieties, thus functionalizing the surface of the nanoparticles.  
A recent successful example of targeting functionality concerns magnetic targeting for 
drug and gene delivery. In this case, targeting is controlled remotely by exploiting a 
magnetic component of the nanoparticle.  
A remote control has also been proposed for triggering drug release by external stimuli 
such as specific radiation, ultrasound, ac magnetic fields, or heat, that act on a sensitive 
component, integrated within the nanoparticle. On the other hand, controlled release can be 
generated by including responsive components such as pH sensitive lipids and/or polymers 
or molecules, which can be processed and activated by enzymes that localize specifically 
to the disease site. Although no second generation nanoparticle has yet been approved by 
the American Food and Drug Administration, numerous current clinical trials involve 
targeting of nanoparticles.  
More recent advancements concern a third generation of nanoparticles
5
. These are 
multicomponent and multifunctional systems where different nanoparticles are nested into 
a single construct. In these systems the functions of biorecognition, toxicity and biological 
barrier avoidance are decoupled, however they act in sequence and in synergy. An example 
of third generation nanoparticles are the so called nano-shuttles, which are self-assemblies 
of gold nanoparticles within a bacteriophage matrix
6. Another example is the “nanocell” 
that comprises a lipid based nanoparticle, enveloping a polymeric core. A conventional 
                                                 
4 Prato M. et al. Acc. Chem. Res, 2008, 41, 60 
5 Riehemann K. et al. Angew. Chem. Int. Ed., 2009, 48, 872 
6 Souza G.R. et al. Proc. Natl. Acad. Sci. U.S.A., 2006, 103,1215 
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cancer drug is conjugated to the polymer core and an anti-angiogenic agent is included in 
the lipid envelope. When nanocells accumulate in tumor cells by a passive mechanism, the 
sequential release of the antio-angiogenic agent and of the cytotoxic drug causes an initial 
disruption of tumor vascular growth and traps the drug conjugated nanoparticle core within 
the tumor to allow eventual delivery of the cytotoxic drug
7
. Silica nanoparticles are another 
example of third generation nanoparticles. They have been designed for being actual 
sequential multi-stage systems that should be capable of crossing biological barriers and 
reaching their target, due to decoupled functions of their single components
8
. 
Liposomes as drug delivery systems (DDS)  
As mentioned above, liposomes, or vesicles, are nanoparticles consisting of closed bilayers 
(one or more) of amphiphilic molecules that include a 
part of the aqueous medium in which they are 
dispersed. (Figure 1.1). Amphiphilic molecules that 
form liposomes can be lipids of natural origin 
(phospholipids, glycolipids) and all those surfactants 
with low solubility in water, with the polar head 
relatively small and relatively bulky hydrophobic 
region. Since their first description in 1965, liposomes 
had a dual role: on the one hand they represent a 
versatile model of cell membranes
9
, on the other hand, 
are flexible and well characterized drug delivery 
systems that can be used for the transport of a wide range of compounds (drugs, nucleic 
acids, enzymes) within cells and tissues. The formation and organization of these systems 
through non-covalent bonds have several advantages i) ease preparation, ii) complete 
biocompatibility, if composed of natural phospholipids, iii) possibility of loading 
hydrophilic and hydrophobic molecules (however, more suitable drugs to be delivered by 
liposomes are those that have a high oil/water partition coefficient and that do not need to 
be administered in high doses), iv) protection of the encapsulated substances from the lytic 
enzyme (such as proteases or nucleases) action, or from denaturing environments; v) 
facilitating active substances to be internalized by cells, vi) capability, as a function of 
                                                 
7 Sengupta S. et al. Nature, 2005, 436,568  
8 Tasciotti E. et al. Nanotechnol., 2008, 3,151  
9 Allen M et al. Advanced Drug Delivery Reviews, 2013, 65, 36 
Figure 1.1. Liposome 
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composition, size and surface charge, to specifically release drug into cells with phagocytic 
activity and to localize at the level of specific tissues and organs, vii) ability to decrease the 
toxicity of certain active principles avoiding, for example, the accumulation in the heart 
(doxorubicin) or in kidneys (amphotericin B).  
On the basis of their size and number of bilayers, liposomes can be classified as i) 
multilamellar vesicles (MLV), i.e. vesicles composed of many lipid bilayers and 
characterized by a diameter >500 nm; ii) large unilamellar vesicles (LUV) characterized by 
a single lipid bilayer and by a diameter >100 nm; and iii) small unilamellar vesicles (SUV) 
characterized by a single lipid bilayer and a diameter of 20-100 nm.  
Liposomes can be also classified on the basis of their composition and functions (Figure 
1.2) as
10
 a) conventional: prepared from neutral phospholipids, lecithin or sphingomyelin 
as main constituents, using cholesterol, negatively charged phospholipids and synthetic 
lipids as additives. In vivo, when administered intravenously, they are removed within a 
few hours by the RES macrophages. Therefore, these liposomes are used as drug carriers 
when the target organ is RES, where are often localized bacteria, fungi and parasites. b) 
inert (Stealth):  they do not interact with biological fluids, and with the RES cells thus 
being able to remain in the bloodstream for longer times compared to the conventional 
liposomes. STEALTH ® liposomes belong to this category; they are formulated with 
specific lipids, such as the ganglioside GM1, phosphatidylinositol hydrogenated HP1, 
which give the liposomes an average life-time of up to twelve hours, compared to the 
minutes of conventional formulations. The inert liposomes, escaping the uptake of RES, 
remain in circulation for longer times with respect to conventional liposomes. Considering 
the fact that the blood vessels in tumors are fenestrated and therefore accessible to 
liposomes, a longer life bloodstream promotes the accumulation in tumors and inflamed 
tissues (passive targeting); so they are the most suitable for systemic administration to 
tumors and inflamed tissues; c)  reactive: liposomes with fusogenic properties and/or 
sensitive to certain external stimuli such as pH or concentration of a particular ion, such as 
calcium. These liposomes are often defined as polymorphs because they undergo a phase 
change upon the interaction with the cell environment. An example of reactive liposomes 
are those formulated with lipids that form vesicles at a pH close to neutrality and give 
micelles at a lower pH thus triggering the release of the encapsulated content. Because 
generally tumor tissues feature a pH lower than the physiological one, these liposomes are 
                                                 
10 Lasic D.D. et al. Science, 1995, 217, 1245 
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particularly interesting in the formulation of drug delivery system for cancer therapy
11
; d) 
specific or targeted: these are stabilized liposomes specifically functionalized with 
antibodies or receptor ligands  (for example, folic acid, sugars) (active targeting). In the 
class of targeted liposomes can be listed also magnetic liposomes, these are obtained by 
entrapping magnetic material in the core of lipid vesicles. The application of external 
magnetic field will convey the magnetic liposomes to the target. Several groups have 
investigated the use of magnetoliposomes for site specific targeting, cell-sorting and as 
magnetic resonance contrast enhancing agents
12
. For example Babincova et al.
13
 have used 
doxorubicin (DOX) carrying magnetoliposomes for site specific chemotherapy in response 
to externally applied AC magnetic field. The results of this study showed that 
magnetoliposomes can be specifically heated to 42°C for a few minutes to obtain the 
massive release of the encapsulated doxorubicin.  An in vivo study on the administration of 
adriamycin (ADR) encapsulated in magnetoliposomes showed that the application of an 
external magnetic field yielded a ~ 4-fold higher ADR concentration in the tumor with 
respect to free ADR. This result showed that systemic chemotherapy could effectively 
                                                 
11 Wang C.Y. et al. Biochim. Biophys. Res. Commun., 1987, 147, 980; Immordino M.L. et al. Int. J. 
Nanomedicine 2006, 1(3), 297 
12 Saiyed Z. M. et al. BioMagnetic Research and Technology, 2003, 1:2 
13 Babincová M. et al. Bioelectrochemistry, 2002, 55, 17 
 
 
Figure 1.2. Different type of liposomes used 
as DDS. From Laic D. D. et al. J. of 
Controlled Release, 1997, 48, 203. 
 
10 
 
control the primary tumor without significant side effects, due to the targeting of magnetic 
ADR liposomes
14
.  
Other liposomes that can be classified as specific are the cationic liposomes. These are 
liposomes formulated with cationic synthetic lipids, and the positive charge of their surface 
ascribe them a specific biological behavior. The first cationic liposomes, formulated with 
dioleoilfosfatidiletanolammina (DOPE) and chloride of N-[1-(2,3-dioleilossi)propyl]-
N,N,N-trimethylammonium (DOTMA), a synthetic cationic lipid, were proposed in 1987 
to introduce a plasmid into cell lines. Since then, many other cationic formulations have 
been used in gene therapy protocols. Over the past ten years there has been a renewed 
interest in these systems, because they are characterized by an intrinsic selectivity towards 
certain organs and/or tissues such as the endothelium of tumor vessels, liver, and lungs
15
.  
Furthermore, it has been demonstrated that cationic liposomes are able to induce apoptosis 
in macrophages and lymphocytes
16
.  
 
Active targeting: glycosylated liposomes   
Some of the molecules used to attribute active targeting to liposomes are, as mentioned 
above, sugars residues
17
. Molecular recognition events involving carbohydrates occur in a 
wide variety of important biological processes including the functions of the immune 
system, interaction of viruses and bacteria, and tissue growth. Cell-to-cell communication 
events, which are driven by highly specific carbohydrate-protein interactions, are included 
in these recognition phenomena. These specific interactions occur through the interaction 
of glycolipid, glycoprotein, or polysaccharide found on cell surfaces and lectins, proteins 
characterized by the presence of  carbohydrate-binding sites
18
. 
The functionalization of liposome surface with sugars moieties is generally obtained by 
including in the lipid formulations glycosylated amphiphilic molecules. In these molecules 
the polar sugar residue(s) is(are) linked  to a hydrophobic region, constituted by one or 
more hydrophobic alkyl chains that have the role of anchoring the sugar moiety to the 
liposome bilayer, through a hydrophilic spacer, which has the role of ensuring a good 
exposure of the sugar on the surface of the liposome. The architecture of these sugar-
                                                 
14 Kubo T. et al. Int. J. Oncol., 2001, 18,121 
15 Dass C.R. et al. J. Control. Rel., 2006, 113, 155 
16 Aramaki Y. et al. FEBS Lett, 1999, 460, 472; Aramaki Y. et al.,Pharm. Res., 2000,17, 515 
17 Keerti J. et al. Biomaterials, 2012, 33, 4166; Faivre V. et al., Expert Opin Drug Deliv., 2010,7, 1031  
18 Guo C.X. et al.J. Phys. Chem., 2005,109, 18769 
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carrier molecules is crucial in determining the chemical and physical stability of liposomes 
as well as their specificity towards target proteins.  
Faivre et al.
19
 studied the interactions of different proteins - specific receptors of fucose 
and glucose respectively – with mixed liposomes composed of dimyristoyl-
phosphatidylcholine (DMPC) and synthetic glycolipids bearing units of fucose and 
glucose. Their results showed that the liposome agglutination induced  by the proteins 
increased as a function of the increase, from 40% to 60%, of the amount of glycolipids in 
the lipid formulation.  
In the study of Stimac et al.
20
 liposomes were formulated including 30% of two different 
mannosylated amphiphiles in liposomes of egg-phosphatidylcholine/cholesterol/ 
dicetylphosphate. The results of the investigation showed that the presence  of the 
mannosylated compounds in the formulation affected the size and structural features of the 
liposomes. The study of the interaction of mannosylated liposomes with Concanavalin A 
(ConA), a plant lectin specific for different type of sugars, showed  that the nature of the 
mannosylated lipid strongly controls the interaction with the protein. In conclusion, the 
literature reports on the physicochemical characterization of glycosylated liposomes cleary 
demonstrate that the  nature of the glycolipid influences both the organization and stability 
of the liposomes  and their interaction with receptors.   
Other reports concern in vivo investigation on drug targeting that exploit galactose-receptor 
interaction on the alveolar macrophages
21
 or HIV virus
22
 and mannose-receptor interaction 
on Kupffer cells
23
 or various macrophages
24
. In particular Shimada et al.
25
 reported on the 
biological behavior (in vitro and then in vivo) of synthetic glycolipids included in 
liposomes of dipalmitoylphosphatidylcholine (DPPC). The investigated glycolipids were 
characterized  by the different length of the polyethylene chain (PEG10, PEG20 and PEG40) 
connecting the sugar moiety to the hydrophobic region. The agglutination experiments 
with the galactose-specific lectin-agarose from Ricinus Communis (RCA-120) showed that 
only in the presence of  the PEG10 chain ( from 9 Å to 35 Å ) the galactose moieties were 
                                                 
19 Faivre V. et al. Chemistry and Physics of Lipids, 2003, 125,147 
20 Štimac A. et al., Biochimica et Biophysica Acta, 2012, 1818, 2252   
21Chono S. et al. Drug Dev. Ind. Pharm., 2010, 36,102;  Chono S. et al. J. Control Rel., 2008, 127, 50 
22 Minakshi G. et al. Eur. J. Pharm. Sci., 2008, 33, 271 
23-25 Shimada k. et al. Biochimica et Biophysica Acta, 1997, 1326, 329 
24 Jain S. et al. Journal of drug delivery, 2011, 2011 
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properly exposed for an adequate interaction with the lectin. The in vivo experiments using 
liposomes with PEG10 showed that the uptake and the recognition in the Kupffer cells was 
faster compared to control liposomes. 
In the work of Garg et al. units of galactose, fucose and mannose sugar were esterified 
with palmlitoyl chloride in dimethylformamide to obtain galactosylated, fucosylated and 
mannosylated liposomes
26
. The authors investigated the hepatic toxicity, cellular uptake 
and pharmacokinetics of stavudine
27
 and azidothymidine
28
 entrapped in two different 
galactosylated liposomes (Gal-Lip) . They found that stavudine entrapped in galactosylated 
liposomes did not show the hematological and hepatic toxicity in the presence of a high 
uptake of galactosylated formulations by liver parenchymal cells from albino rats. 
Analogously hematological toxicity was not observed for 10 days in the case of 
azidothymidine loaded in galactosylated vesicles. Cellular uptake of azidothymidine-Gal-
Lip was 8.5 and 1.8 folds larger compared to free drug and uncoated liposomes, 
respectively, and there was a prolonged release with higher accumulation to tissues 
compared to normal liposomes. Matsui and coworkers
29
 developed oligomannose-coated 
liposomes of dipalmitoylphosphatidylethanolamine  (DPPE) as delivery systems for 
anticancer drugs and found that these carriers were successfully taken up by mouse 
peritoneal macrophages and the anticancer drugs were carried to metastatic sites in the 
peritoneal cavity in mice. The clinical application of this system to gastric cancer patients 
was investigated to verify whether the oligomannose-coated liposomes could be up taken 
by human peripheral blood monocytes and human peritoneal macrophages to carry them to 
micrometastatic foci in the mouse omentum and resected omentum from cancer patients in 
ex vivo studies. Finally the authors suggested that oligomannose-coated liposomes can be 
successfully explored for the delivery of anticancer drugs to the metastatic sites via 
selective uptake by peritoneal macrophages through receptor mediated endocytosis. 
Kaur et al. developed surface engineered liposomes including positively charged, 
negatively charged and mannose coated liposomes for specific targeting of zidovudine, an 
                                                 
26-27 Minakshi G., Eur. J. Pharm. Biopharm., 2007, 67, 76 
28 Minakshi G., J. Drug Target, 2006, 14, 1 
29 Matsui M et al., Cancer Science, 2010, 101, 1670 
30 Chanchal D.K., J. Drug Target., 2008, 16, 798 
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antiviral drug, to lymph nodes and spleen
30
. The authors obtained the positively charged, 
negatively charged and mannose coated vescicles using stearylamine, dicetyl-phosphate 
and mannose-terminated stearylamine, respectively. In organ distribution studies, reduced 
concentration of zidovudine in serum with increased amounts in the spleen and lymph 
nodes was observed by using mannose coated liposomes. Fluorescent microscopic studies 
showed a high localization of surface engineered liposomes in the lymph nodes and spleen 
with highest uptake of mannose coated liposomes followed by the negatively charged and 
then by the positively charged liposomes with minimum uptake of plain liposomes. It was 
concluded that zidovudine loaded mannose coated liposomes could be exploited as 
potential carriers for the treatment of viral diseases such as AIDS whose  target site is the 
lymphatic system. 
Aim of the work  
The aim of this work is the synthesis and the characterization of cationic glycosylated 
amphiphiles (GA) to be included in liposome formulations to ascribe them both a positive 
charge and specificity toward sugar receptors. A number of synthetic possibilities will be 
explored by exploiting glucose as sugar residue (Chart 1.1, glycolipids 1-4). A synthetic 
procedure explored on glucose will be then extended to lactose because most human 
lectins are galactose receptors (Chart 1.1, glycolipid 5). Liposomes composed of 
phospholipids and defined GA, i.e. GA 1 and 4 will be characterized by different 
physicochemical techniques such as dynamic light scattering, UV and fluorescence 
spectroscopy.  The potentiality of these liposome formulations as targeting drug delivery 
systems will be ascertained by investigating their interaction with Con A, a plant lectin 
derived from the Jack Bean (Canavalia ensiformis), that provides an optimal model system 
for the study of multivalent lectin binding. In fact Con A exists as a tetramer, four chains, 
in basic conditions, each monomer featuring a glucose binding site
31
. The interaction with 
Con A will be studied by experimental techniques such as dynamic light scattering, UV 
and fluorescence spectroscopy and by a theoretical approach based on molecular docking, 
useful to describe the interaction of a single GA with the protein, and molecular dynamic 
simulations that will give an atomistic description of the interaction between the protein 
                                                 
 
 
31 Glen B.T. et al. J. Am. Chem. Soc., 2009, 131(15), 5471 
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and the lipid bilayer formed by a phospholipid and one of the GAs. The theoretical 
approach will allow rationalizing the experimental findings and identifying the role of 
some structural features of the GA to address a rational design of new GAs.  
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Chart 1.1. Glycosylated cationic amphiphiles. 
The theoretical investigation will rely on the study of the binding of glycosylated lipid 
bilayers with a single monomeric unit of ConA, (PDB code 3D4K
32
, Chain A). The protein 
is composed of 237 aminoacids and the structure of the complex formed by ConA with a 
trimannoside was elucidated by X-rays
32
. The aminoacid residues of the binding site 
involved in the binding with the trimannoside are Asparagine 14 (Asn 14), Leucine 99 
(Leu 99), Tyrosine 100 (Tyr 100), Aspartic acid 208 (Asp 208), Arginine 228 (Arg 228) as 
shown in Figure 1.3. The ConA contains two metal binding site, site S1 binds Mn
2+
 ion 
while site S2 binds Ca
2+
 ion. The manganese ion (Mn 238) is octahedrally coordinated to 
the following aminoacidic residues: Glutammic acid 9 (Glu 9), Asp 10, Asp 19, Histidine 
24 (His 24), and two water molecules. The calcium ion (Ca 239) is seven fold coordinated 
and interacts with two oxygen atoms from Asp 10 as well as with residues Tyr 12, Asn 14, 
Asp 19 and two water molecules. The presence of the two metal ions is fundamental for 
the binding o saccharidic moiety with the protein.  
 
                                                 
32 Kadirvelraj R et al. J. Am. Chem. Soc., 2008, 130, 16933 
15 
 
 
Figure 1.3. Visualization of the aminoacidic residues 
involved in the binding with ConA. From Kadirvelraj R. 
et al. J. Am. Chem. Soc., 2008, 130, 16933.  
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Chapter 2 
Synthesis and characterization of novel glycosylated amphiphiles 
This chapter describes the synthesis and characterization of the five novel glycosylated 
amphiphiles 1, 2, 3, 4 and 5 reported in Chart 2.1. 
 
                                                                               Chart 2.1. 
Experimental 
Instrumentation 
NMR spectra were recorded on a Bruker300 Avance spectrometer (operating at 300.13 for 
1
H and 75.47 MHz for 
13
C) and on a Bruker 400 Avance spectrometer (operating at 400 
MHz for 
1
H and 100 MHz for 
13
C). Deuterated solvents were used as internal standards.  
HRMS-ESI spectra were recorded on a LTQ Orbitrap XL instrument.  
Steady-state fluorescence experiments were carried out on a Fluoromax-4 Horiba-
JobinYvon spectrofluorimeter.  
Conductivity measurements were carried out on a Hanna conductimeter, HI-9932, equipped 
with a thermostating apparatus, in the temperature range 4–60 °C. All measurements were 
done in a jacketed cell that was maintained at the appropriate temperature (±0.1 °C).  
Dynamic laser light scattering (DLS) measurements were performed with a Malvern Nano-
ZetaSizer spectrometer, equipped with a 5 mWHeNe laser (wavelength = 632.8 nm) and a 
digital logarithmic correlator. 
17 
 
Materials 
D(+)-Glucose was purchased from Merck. Fluoresceinisothiocyanate labeled Concanavalin 
A (FITC-ConA) was purchased from Invitrogen. Phosphate buffer saline (PBS) tablet (0.01 
M phosphate buffer, 0.0027 M KCl, 0.137 M NaCl, pH 7.4 at 25° C) and all the starting 
materials for the synthesis were purchased from Sigma-Aldrich. 
 
Synthesis of amphiphiles 1, 2, 3, 4, 5 
Preparation of 2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl-4methylbenzensulphonate 9   
 
HO
O
OH
3
TsO
O
OH
3
TsCl
 THF, NaOH 6M
8 9 (70%)  
 
10 mL of NaOH 6 M and 45 mL of tetraethyleneglycol 8 (0.26 mol) were added to 10 mL 
of THF at 0°C. A solution of 5.0 g of tosyl chloride (TsCl) (26.2 mmol) in 30 mL of THF 
was added dropwise and the reaction mixture was stirred until complete addition of TsCl. 
The mixture was then diluted with 200 mL of THF and 800 mL of water and NaCl was 
added until complete phases separation. The organic layer was separated, the solvent was 
removed under reduced pressure and the residual dissolved in CH2Cl2. The organic phase 
was extracted with water (10 x 150 mL) and dried over anhydrous Na2SO4. The solvent was 
removed under reduced pressure to afford 6.4 g of 9 (yield 70%) as a pale yellow oil.   
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 2.43 (s, 3H, CH3); 2.65 (s, 1H, OH);3.59-3.68 (m, 14H, 
CH2OCH2, CH2OH); 4.15 (t, 
3
JHH =6.50 Hz, 2H, CH2OTs); 7.32-7.75 (m, 4H, aromatic). 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 22.33 (CH3); 61.74, 68.76, 69.27, 70.35, 70.45, 70.69, 70.76, 
72.45 (CH2OCH2, CH2OH); 128.02, 129.86, 138.21, 140.83 (aromatic). 
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Preparation of 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethanol 10 
 
TsO
O
OH
3
N3
O
OH
3
NaN3
DMF dry, 70°C
9 10 (77%)  
 
1.98 g of 9 (5.7 mmol) and 0.5 g of NaN3 (7.6 mmol) were suspended in 10 mL of dry DMF 
under nitrogen. The mixture was stirred and heated at 70°C for 14 hours. The solvent was 
removed under high vacuum and the oily residue was washed with CH2Cl2. After filtration 
the solvent was removed under reduced pressure to afford 0.96 g of 10 (yield 77%) as a 
yellow oil.  
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 2.81 (s,1H, OH); 3.38 (t, 
3
JHH =6.02 Hz, 2H, CH2N3); 
3.61-3.70 (m, 14H, CH2OCH2, CH2OH). 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 50.67; 61.70; 70.05; 70.35; 70.60; 70.66; 70.70; 72.48. 
19 
 
Preparation of 2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)ethanol 11 
 
N3
O
OH
3
N3
O
Br
3
PBr3
CH2Cl2 dry, 0°C.
10 11 (61%)  
 
0.96 g of 10 (4.4 mmol) were dissolved in 15 mL of dry CH2Cl2 under nitrogen. The 
mixture was cooled to 0°C and a solution of 0.13 mL of PBr3 (1.46 mmol) in 10 mL of dry 
CH2Cl2was added dropwise. The reaction was then neutralized by aqueous NaHCO3 
saturated solution. The aqueous phase was extracted with CH2Cl2 (2 x 20 mL), the combined 
organic layers were dried over anhydrous Na2SO4 and, after filtration and the solvent was 
removed under reduced pressure. The oily residue was purified by silica gel cromatography 
(eluent CHCl3) to afford 0.75 g of 11(yield 61%). 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 3.37 (t, 
3
JHH =6.04 Hz, 2H, CH2N3); 3.47 (t, 
3
JHH =6.65 
Hz, 2H, CH2Br); 3.65-3.70 (m, 10H, OCH2CH2O, CH2CH2N3); 3.82 (t, 
3
JHH=6.65 Hz, 2H, 
CH2CH2Br). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 50.67; 61.70; 70.05; 70.35; 70.60; 70.66; 70.70; 72.48. 
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Preparation of propargil-β-D-glucopiranoside 7 
 
O
AcO
OAc
OAc
KOH 1M
EtOH, r.t.
AcO
O
O
HO
OH
OH
HO
O
6 7 (58%)  
 
20mL of aqueous KOH 1M were added to a solution of 1.01 g of 2-propinil-tetra-O-acetil-
β–D-glucopiranoside 6 (2.6 mmol) in 60 mL of EtOH. The mixture was stirred at room 
temperature for 1.5 hours and then neutralized by the addition of Amberlite IR-120. After 
filtration the solvent was removed under reduced pressure and the residue was purified by 
silica gel cromatography (eluent CH2Cl2/MeOH=8/2) to give 0.34 g (1.5 mmol) of 7 (yield 
58%) as pale yellow oil. 
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 2.86 (t, 
4
JHH =2.88 Hz, 1H, H9); 3.20 (t,
 3
JHH =8.33 
Hz,1H, H2); 3.26-3.41 (m, 3H, H3
 
,H4 ,H5); 3.63-3.69 (m, 1H, H6); 3.84-3.89 (m, 1H, H6); 
4.41-4.45 (m, 2H, H7); 4.45 (d, 
3
JHH =8.33 Hz,1H, H1). 
 
13
C-NMR (δ CD3OD, 75 MHz) ppm: 55.20; 61.25; 70.03; 72.89; 74.18; 76.45; 76.50; 79.46; 
100.65 (C1). 
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Preparation of triazolic adduct 12 
 
O
HO
OH
OH
HO
O
N3
O
Br
3
O
HO
OH
OH
HO
O
N N
N
O
Br
3H2O/t-BuOH=1/1,r.t.
CuSO4 0.3M
ascorbic acid 1M
.
7 12 (86%)
11
 
 
0.42 g of 11 (1.5 mmol) and 0.32 g of 7 (1.5mmol) were suspended in 6 mL of H2O/t-BuOH 
(1:1). 150 l of a freshly prepared aqueous solution of ascorbic acid 1 M and 50 l of an 
aqueous solution of CuSO4∙5H2O 0.3 M were then added to the mixture. The reaction was 
stirred at room temperature for 1 day. The mixture was then cooled to 0°C, neutralized by 
NaHCO3 and the solvent was removed under reduced pressure. The residue was washed 
with MeOH, filtered to remove salts and the solvent was removed under reduced pressure. 
The crude product was purified by silica gel cromatography (eluent CHCl3/MeOH=85/15) 
to give 0.65 g (1.3 mmol) of 12 (yield 86%) as a pale yellow oil.  
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 3.20 (t, 
3
JHH =8.69 Hz, 1H, H2); 3.29-3.35 (m, 3H, 
H3, H4, H5); 3.51 (t, 
3
JHH =6.52 Hz, 2H, H17); 3.58-3.70 (m, 9H, H12, H13, H14, H15, 
H6(1H)); 3.79 (t, 
3
JHH =6.52 Hz, 1H, H16); 3.90 (m, 2H, H11,
 
H6(1H)); 4.39 (d, 
3
JHH =8.69 
Hz, 1H, H1); 4.53 (t, 
3
JHH =6.25 Hz,2H, H10); 4.76-5.02 (m, 2H, H7); 8.15 (s, 1H, H9). 
 
13
C-NMR (δ CD3OD, 75 MHz) ppm: 30.15 (C17); 49.85 (C10); 61.45 (C6); 61.66 (C7); 
69.01 (C11); 70.04, 70.11, 70.16, 70.26 (C5, C12, C13, C14, C15); 70.96 (C16); 73.66 
(C2); 76.61 (C3); 76.67 (C4); 102.15 (C1); 124.32 (C9); 144.11 (C8). 
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Preparation of N-didodecyl-N-methylamine 
 
 
 
A solution of 1.0 mL (3.9 mmol)of N-methyldodecylamine and 1.1 mL (3.6mmol) of 1-
bromododecane in 2 mL of absolute EtOH was heated at reflux for one day. Upon cooling 
the solid residue was filtered, washed with n-hexane and crystallized from EtOH to afford 
0.96 g (yield 73%) of the pure product as a pale yellow powder. 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 0.88 (t, 
3
JHH =7.54 Hz, 6H, CH2CH3); 1.26-1.38 (m, 
40H, NCH2(CH2)10CH3); 2.26 (s, 3H, NCH3); 2.46 (t, 
3
JHH =7.08 Hz , NCH2). 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 14.10 (CH2CH3); 22.65; 27.33; 28.13; 29.55; 29.36; 
32.05; 60.68. 
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Preparation of glucosylated amphiphile, GA 1 
 
O
HO
OH
OH
HO
O
N N
N
O
Br
3
N
O
HO
OH
OH
HO
O
N N
N
O
N
3
15
15
Br
CH3CN, ref.
12 1 (55%)  
 
0.65 mL of N,N-dimethyl-N-hexadecylamine (1.95mmol) and 0.65 g of 12 (1.3mmol) were 
suspended in 10 mL of CH3CN. The mixture was heated at reflux for one week. The solvent 
was removed under reduced pressure and the residue was washed several times with Et2O to 
give 0.55 g (0.71 mmol) of the product 1 (yield 55%). 
 
1
H-NMR (δ CD3OD, 400 MHz) ppm: 0.81 (t, 
3
JHH =7.66 Hz, 3H, H35); 1.22-1.42 (m, 26H, 
H22, H23, H24, H25, H26, H27, H28, H29, H30, H31, H32, H33, H34); 1.79 (m, 2H, H21); 
3.18 (s, 6H, H18, H19); 3.21 (t, 
3
JHH =7.96 Hz, 1H, H2); 3.29-3.47 (m, 4H, H3, H4,
 
H5, 
H20); 3.56-3.79 (m, 11H, H6(1H), H12, H13, H14, H15, H17); 3.83-3.92 (m, 5H, H6(1H), 
H11); 4.41 (d, 
3
JHH =7.96 Hz, 1H, H1); 4.59 (t, 
3
JHH =6.38 Hz, 1H, H10); 4.76-5.00 (m, 2H, 
H7); 8.11 (s, 1H, H9). 
 
13
C-NMR (δ CD3OD, 100 MHz) ppm: 13.15 (C35); 21.74, 22.36, 22.53, 26.06, 28.92, 
29.09, 29.23, 29.30, 29.38, 29.42, 31.69 (C21, C22, C23, C24, C25, C26, C27, C28, C29, 
C30, C31, C32, C33, C34); 50.09 (C10); 51.00 (C18, C19); 61.34 (C6); 61.68 (C7); 63.08 
(C17); 64.43 (C16); 65.62 (C20); 68.98 (C11); 70.01, 70.15, 70.25 (C5,
 
C12, C13, C14, 
C15); 74.01 (C2); 76.60 (C3); 76.64 (C4); 102.22 (C1); 124.72 (C9); 144.11 (C8). 
HRMS: calculated for C35H69N4O9 [M-Br
-
]
+
: 689.5065;found: 689.5086. 
 (CH3OH, C=0.81) 10.35° 
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Preparation of GA 2 
 
 
O
HO
OH
OH
HO
O
N N
N
O
Br
3
N
O
HO
OH
OH
HO
O
N N
N
O
N
3
11
11
Br
CH3CN, ref.
12 2 (56%)  
 
GA 2 was prepared with a 56% yield by alkylation of N-dimethyl-N-dodecylamine with 
compound 12 according to the procedure described above for the preparation of GA1.  
 
1
H-NMR (δ CD3OD, 400 MHz) ppm: 0.81 (t, 
3
JHH =7.66 Hz, 3H, H31); 1.22-1.42 (m, 18H, 
H22, H23, H24, H25, H26, H27, H28, H29, H30); 1.79 (m, 2H, H21); 3.18 (s, 6H, H18, 
H19); 3.21 (t, 
3
JHH =7.96 Hz, 1H, H2); 3.29-3.47 (m, 4H, H3, H4, H5, H20); 3.56-3.79 (m, 
11H, H6(1H),
 
H12, H13, H14, H15, H17); 3.83-3.92 (m, 5H, H6(1H),
 
H11); 4.41 (d, 
3
JHH 
=7.96 Hz, 1H, H1); 4.59 (t, 
3
JHH =6.38 Hz, 1H, H10); 4.76-5.00 (m, 2H, H7); 8.11 (s, 1H, 
H9). 
 
13
C-NMR (δ CD3OD, 100 MHz) ppm: 13.10 (C31); 21.72, 22.29, 22.3, 26.10, 28.92, 29.23, 
29.30, 29.42, 29.48, 31.69 (C21, C22, C23, C24, C25, C26, C27, C28, C29, C30); 50.15 
(C10); 51.09 (C18,
 
C19); 61.30 (C6); 61.62 (C7); 63.09 (C17); 64.53 (C16); 65.70 (C20); 
68.85 (C11); 70.00, 70.10, 70.22 (C5, C12, C13, C14, C15); 74.10 (C2); 76.65 (C3); 76.67 
(C4); 102.20 (C1); 124.70 (C9); 144.21 (C8). 
 
O
HO
OH
OH
HO
O
N N
N
O
O
O
N
Br
1
2
3
4
5
6
7
8
9 10
11 12
13 14
15 16
17
18 19
20
21
22
23
24
25
26
27
28
29
30
31
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Preparation of GA 3 
 
O
HO
OH
OH
HO
O
N N
N
O
Br
3
N O
HO
OH
OH
HO
O
N N
N
O
N
3
11
11
Br
CH3CN, ref.
12 3 (48%)
11
11
 
GA 3 was prepared with a 48% yield by alkylation of N-didodecyl-N-methylamine with 
compound 12 according to the procedure described above for the preparation of GA1.  
 
1
H-NMR (δ CD3OD, 400 MHz) ppm: 0.81 (t, 
3
JHH =7.64 Hz, 6H, H30); 1.22-1.42 (m, 36H, 
H21, H22, H23, H24, H25, H26, H27, H28, H29); 1.78 (m, 4H, H20); 3.18 (s, 3H, H18); 
3.21 (t, 
3
JHH =7.96 Hz, 1H, H2); 3.29-3.47 (m, 7H, H3, H4, H5, H19); 3.56-3.79 (m, 11H, 
H6(1H), H12, H13, H14, H15, H17); 3.81-3.92 (m, 5H, H6(1H), H11); 4.41 (d, 
3
JHH =7.96 
Hz, 1H, H1); 4.58 (t, 
3
JHH =6.38 Hz, 1H, H10); 4.76-5.00 (m, 2H, H7); 8.15 (s, 1H, H9). 
 
13
C-NMR (δ CD3OD, 100 MHz) ppm: 13.10 (C30); 21.72, 22.28, 22.32, 26.15, 28.92, 
29.25, 29.41, 29.42, 29.48, 31.69 (C20, C21, C22, C23, C24, C25, C26, C27, C28, C29); 
50.15 (C10); 51.22 (C18); 61.29 (C6); 61.62 (C7); 63.15 (C17); 64.52 (C16); 65.85 (C20); 
68.85 (C11); 69.89, 69.97, 70.15 (C5, C12, C13, C14, C15); 74.10 (C2); 76.65 (C3); 76.67 
(C4); 102.20 (C1); 124.81 (C9); 144.25 (C8). 
O
HO
OH
OH
HO
O
N N
N
O
O
O
N
Br
1
2
3
4
5
6
7
8
9 10
11 12
13 14
15 16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 2
+
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Preparation of penta-O-acetyl-β-D-glucopyranoside 14 
 
O
HO
OH
OH
HO O
AcO
OAc
OAc
AcO
OAc
Ac2O, AcONa
130°C
13 14(67%)
OH
 
 
16.1 g of AcONa (0.2 mol) were suspended in 68 mL of acetic anhydride and the mixture 
was heated to 130 °C. 5.0 g of glucopyranose 13 (0.027 mol) were added and the reaction 
was stirred for 16 hours. 350 mL of ice and water were then added to the cooled mixture and 
the suspension was stirred overnight. After filtration a pale brown solid was obtained that 
was purified by crystallization from EtOH to give 7.1 g of 14 (yield 67%) as a white solid.  
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 1.98-2.14 (m, 15H, 5OAc); 3.79-3.86 (m, 1H, H5); 
4.07-4.15 (m, 1H, H6); 4.24-4.32 (m, 1H, H6); 5.08-5.17 (m, 2H, H2, H3, H4); 5.23 (t, 
3
JHH 
=8.55 Hz, 1H, H3); 5.72 (d, 
3
JHH =8.52 Hz, H1). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 20.58, 20.72, 20.83 (CH3, OAc); 61.44, 67.73, 70.22, 
72.73,72.80 (C2, C3, C4, C5, C6); 91.70 (C1); 168.98, 169.26, 169.40,170.12, 170.62 (CO, 
OAc). 
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Preparation of 2-(2-(2-propargyloxyethoxy)ethoxy)ethanol 16 
 
 
HO
O
OH
2
Br
HO
O
3THF dry, r.t.
t-BuOK
15 16 (51%)  
 
3.5 mL of triethylene glycol 15 (26 mmol) were dissolved in 150 mL of dry THF under 
nitrogen. Molecular sieves (4Å) and 2.9 g of t-BuOK (26 mmol) were added and the 
mixture was stirred for 1 hour. 2.9 mL of propargyl bromide (26 mmol) were then added 
dropwise and the reaction was stirred at room temperature overnight. The mixture was 
filtered over celite washing with CH2Cl2, and the solvent was removed under reduced 
pressure. The oily residue was purified by silica gel cromatography (eluent AcOEt) to give 
2.53 g of 16 (13.4 mmol, yield 51%) as pale yellow oil.  
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 2.36 (t,
 4
JHH =2.35 Hz, 1H, CH); 3.15 (s, 1H, OH); 
3.35-3.61 (m, 12H, CH2OCH2, CH2OH); 4.04 (d, 
4
JHH =2.35 Hz, 2H, CH2CCH). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 58.33, 61.60, 68.85, 70.11, 70.14, 70.41, 72.41 
(CH2OCH2, CH2OH); 74.69, 79.45(sp carbons). 
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Preparation of compound 21 
 
O
AcO
OAc
OAc
AcO
OAc
CH2Cl2 dry
Et2OBF3, 0-25°C
HO
O
3
O
AcO
OAc
OAc
AcO
O
O
3
14 21 (44%)
16
 
 
 
4.60 g of penta-O-acetylglucopyranoside 14 (11.8 mmol) and 1.85 g of 16 (9.8 mmol) were 
dissolved in 35 mL of dry CH2Cl2 under nitrogen. The solution was cooled to 0°C and 7.5 
mL of Et2O∙BF3 (59 mmol) were added dropwise. The reaction mixture was heated to room 
temperature and stirred overnight. The mixture was then neutralized by an aqueous 
NaHCO3satured solution, the aqueous phase was extracted with CH2Cl2 (2 x 20 mL) and the 
combined organic layers were dried over anhydrous Na2SO4. After filtration, the solvent 
was removed under reduced pressure. The oily residue was purified by silica gel 
cromatography (eluent CH2Cl2/AcOEt=7/3) to give 2.23 g of 21 (yield 44%) as a brown oil. 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 1.94-2.15 (m, 12H, OAc); 2.38 (t, 
4
JHH =2.35 Hz, 1H, 
H15); 3.52-3.64 (m, 12H, H5, H7(1H), H8, H9, H10, H11, H12); 3.81-3.94 (m, 1H, H7); 
4.03-4.11 (m, 1H, H6); 4.13 (d, 
4
JHH =2.35 Hz, 2H, H13); 4.14-4.23 (m, 1H, H6); 4.56 (d, 
3
JHH =7.98 Hz,1H, H1, β anomer); 4.92 (t, 
3
JHH =7.98 Hz,1H, H2); 4.96-5.08 (m, 1H, H4); 
5.14 (t, 
3
JHH =8.02 Hz, 1H, H3). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 20.57, 20.59, 20.65, 20.72 (CH3, OAc); 58.35; 61.91; 
68.37; 69.01; 69.06; 70.31; 70.59; 70.63; 74.59; 100.78 (C1); 169.36, 170.25, 170.66, 
171.12 (CO, OAc). 
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Preparation of compound 22 
 
O
AcO
OAc
OAc
AcO
O
O
3
O
HO
OH
OH
HO
O
O
3
KOH 1M
EtOH, r.t.
21 22 (63%)  
 
Compound 22 was prepared as described for the preparation of compound 7. The product 
was obtained in a 63% yield. 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 2.45 (t, 
4
JHH =2.36 Hz, H15); 3.27-3.39 (m, 3H, H2, 
H3, H4); 3.50-3.91 (m, 18H, 4OH, H5, H6, H7(1H), H8, H9, H10, H11, H12); 3.94-4.05 
(m, 1H, H7); 4.15 (d,
4
JHH=2.36 Hz, H13); 4.28 (d,
3
JHH =7.70 Hz, 1H, H1).  
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 58.33; 61.41; 68.60; 68.70; 69.01; 69.73; 70.22; 70.27; 
72.52; 73.37; 74.91; 75.77; 76.38; 79.67; 103.00 (C1). 
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Preparation of triazolic adduct 23 
 
O
HO
OH
OH
HO
O
O
3
N3
O
Br
3
H2O/t-BuOH=1/1,r.t.
CuSO4 0.3M
ascorbic acid 1M
.
O
HO
OH
OH
HO
O
O
3 N N
N
O
Br
3
22 23 (87%)
11
 
 
Compound 23 was prepared as described for the preparation of compound 12. The product 
was obtained in a 87% yield. 
 
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 3.19 (t, 
3
JHH =7.95 Hz, 1H, H2); 3.25-3.40 (m, 3H, 
H3, H4, H5); 3.51 (t, 
3
JHH =6.53 Hz, 2H, H23); 3.57-3.76 (m, 20H, H6(1H), 7(1H), H8, H9, 
H10, H11, H12, H18, H19, H20, H21); 3.79 (t, 
3
JHH =6.53 Hz, 2H, H22); 3.82-3.85 (m, 1H, 
H6); 3.90 (t, 
3
JHH =6.35 Hz, 2H, H17); 3.96-4.04 (m, 1H, H7); 4.31 (d, 
3
JHH =8.02 Hz, H1); 
4.59 (t, 
3
JHH =6.35 Hz, 2H, H16); 4.64 (s, 2H, H13); 8.15 (s, 1H, H15). 
 
13
C-NMR (δ CD3OD, 75 MHz) ppm: 30.12; 49.95; 61.29; 63.55; 68.20; 68.96; 69.35; 69.90; 
69.92; 70.04; 70.11; 70.22; 73.59; 76.53, 76.60, 76.63; 102.26 (C1); 124.47 (C15); 144.16 
(C14). 
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Preparation of GA 4 
 
O
HO
OH
OH
HO
O
O
3 N N
N
O
Br
3
N
15
CH3CN, ref.
O
HO
OH
OH
HO
O
O
3 N N
N
O
N
3
15
Br
23 4 (55%)  
 
GA 4 was prepared with a 55% yield by alkylation of N-dimethyl-N-hexadecylamine with 
compound 23 according to the procedure described above for the preparation of GA1.  
 
1
H-NMR (δ CD3OD, 400 MHz) ppm: 0.89 (t, 
3
JHH =6.92 Hz, 3H, H41); 1.26-1.42 (m, 26H, 
H28, H29, H30, H31, H32, H33, H34, H35, H36, H37, H38, H39, H40); 1.72-1.84 (m, 2H, 
H27); 3.15 (s, 6H, H24, H25); 3.22 (t, 
3
JHH =7.88 Hz, 1H, H2); 3.26-3.42 (m, 5H, H3, H4, 
H5, H26); 3.52-3.78 (m, 22H, H6(1H), 7(1H), H8, H9, H10, H11, H12, H18, H19, H20, 
H21, H23); 3.83-3.94 (m, 5H, H6, H17,
 
H22); 3.98-4.06 (m,1H, H7); 4.33 (d, 
3
JHH =7.88 
Hz, 1H, H1); 4.60 (t, 
3
JHH =6.35 Hz, 2H, H16); 4.65 (s, 2H, H13); 8.15 (s, 1H, H15). 
 
13
C-NMR (δ CD3OD, 100 MHz) ppm: 13.05 (C41); 22.28, 22.34, 26.03, 28.88, 29.07, 
29.19, 29.27, 29.35, 29.39, 31.67 (C27, C28, C29, C30, C31, C32, C33, C34, C35, C36, 
C37, C38, C39, C40); 50.01 (C16); 50.88 (C24, C25); 61.28 (C6); 63.01 (C23); 63.58 
(C13); 64.36 (C22); 65.55 (C26); 68.21 (C7); 68.96, 69.35, 69.95, 69.98, 70.00, 70.11, 
70.21, 73.65 (C5
, 
C8, C9, C10, C11, C12, C17, C18, C19, C20, C21); 75.57 (C2); 76.63 
(C3); 76.65 (C4); 102.91 (C1); 124.41 (C15); 144.10 (C14). 
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Preparation of peracetylated lactose 18 
 
 
Compound 18 was prepared as described for the preparation of compound 14. The product 
was obtained in a65% yield. 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 1.94 (s, 3H, OAc); 2.01(s, 3H, OAc); 2.03 (s, 3H, 
OAc); 2.04 (s, 3H, OAc); 2.05 (s, 3H, OAc); 2.07 (s, 3H, OAc); 2.10 (s, 3H, OAc); 2.13 (s, 
3H, OAc); 3.71-3.78 (m, 1H, H5); 3.81-3.88 (m, 2H, H4, H11); 4.03-4.15 (m, 3H, H
6, 12(1H)
); 
4.41-4.48 (m, 2H, H7, H12(1H)); 4.92 (dd, 
3
J1 = 10.5 Hz, 
3
J2 =3.5 Hz, 1H, H9); 5.02 (dd, 
3
J1  = 9.5 Hz, 
3
J2=8.3 Hz, 1H, H2); 5.08 (dd, 
3
J1  = 10.5 Hz,
3
J2=7.9 Hz, 1H, H8); 5.22 (t, 
3
JHH = 9.5 Hz, 1H, H3); 5.32 (dd, 
3
J1= 3.5 Hz, 
3
J2 =1.1 Hz, 1H, H10), 5.64 (d, 
3
JHH = 8.3 
Hz, 1H, H1). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 20.60, 20.70, 20.73, 20.84, 20.91, 20.93 (CH3, OAc); 
60.9 (C12); 61.8 (C6); 66.7 (C10); 69.0 (C8); 70.5 (C2); 70.8 (C11); 71.0 (C9); 72.7 (C3); 
73.5 (C5); 75.7 (C4); 91.6 (C1); 101.0 (C7); 169.0, 169.2, 169.7, 169.8, 170.2, 170.3, 
170.48, 170.51 (CO, OAc). 
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Preparation of compound 19 
 
 
0.69 g of peracetylated lactose 18 (1.0 mmol) and 0.30 g of 16 (2.0 mmol) were dissolved in 
dry CH2Cl2. 0.33 g (1.5 mmol) of CF3OOAg were added and the mixture was stirred at 
room temperature under nitrogen for 5 min. A 1M solution of SnCl4 (3.0 mmol) in CH2Cl2 
was added dropwise to the mixture upon stirring. After complete conversion of substrate, as 
indicated by TLC chromatography, the reaction was quenched by addition of saturated 
aqueous NaHCO3. The mixture was then filtrate through Celite and the filtrate was extracted 
three times with CH2Cl2. The organic phase was washed with brine, dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by silica gel column 
chromatography (eluent CH2Cl2/AcOEt=8/2) to afford 0.31 g (yield 38%) of product 19. 
 
1
H-NMR (δ CDCl3, 300 MHz) ppm: 1.94 (s, 3H, OAc); 2.01(s, 3H, OAc); 2.03 (s, 3H, 
OAc); 2.04 (s, 3H, OAc); 2.05 (s, 3H, OAc); 2.07 (s, 3H, OAc); 2.10 (s, 3H, OAc); 2.13 (s, 
3H, OAc); 2.37 (t, 
4
JHH =2.35 Hz, 1H, H21); 3.52-3.88 (m, 15H, H4, H5, H11, H13, H14, 
H15, H16, H17, H18); 3.90-4.10 (m, 3H, H6, H12(1H)); 4.15 (d;
4
JHH =2.35 Hz, 2H, H19); 
4.40-4.49 (m, 2H, H7, H12(1H)); 4.56 (d, 
3
JHH = 8.3 Hz, 1H, H1); 4.91 (t, 
3
JHH = 10.5 
Hz,1H, H9); 5.02 (dd, 
3
J1  = 9.5 Hz, 
3
J2=8.3 Hz, 1H, H2); 5.08 (dd, 
3
J1  = 10.5 Hz,
3
J2=7.9 
Hz, 1H, H8); 5.22 (t, 
3
JHH = 9.5 Hz, 1H, H3); 5.32 (dd, 
3
J1= 3.5, 
3
J2 =1.1 Hz, 1H, H10). 
 
13
C-NMR (δ CDCl3, 75 MHz) ppm: 20.60, 20.70, 20.73, 20.84, 20.91, 20.93 (CH3, OAc); 
58.35; 61.91; 68.37; 69.01; 69.06; 70.31; 70.59; 70.63; 74.59; 77.52;100.62 (C1), 101.09 
(C7); 169.09, 169.70; 169.79, 170.08, 170.17, 170.37, 170.41 (CO, OAc). 
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Preparation of compound 20 
 
 
 
Compound 20 was prepared as described for the preparation of compound 7. The product 
was obtained in a 55% yield. 
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 2.91 (t, 
4
JHH =2.35 Hz, 1H, H21); 3.30 (t, 
3
JHH =9.02 
Hz, 1H, H2); 3.41-3.79 (m, 28H , 8OH,  H2, H3, H4, H5, 6(1H), H8, H9, H11, H12, 
H13(1H), H14, H15, H16, H17, H18); 3.81-3.88 (m, 2H, H6(1H), H10); 3.90-4.07 (m, 1H, 
H13); 4.18 (d, 
4
JHH =2.35 Hz, 2H, H19); 4.34-4.36 (m, 2H, H1, H7). 
 
13
C-NMR (δ CD3OD, 75 MHz) ppm: 68.67; 61.41; 68.60; 68.70; 69.59; 69.73; 70.18; 70.34; 
72.52; 73.33; 74.97; 75.77; 76.30; 79.67; 100.84 (C
7
); 103.00 (C
1
). 
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Preparation of compound 24 
 
 
 
Compound 24 was prepared as described for the preparation of compound 12. The product 
was obtained in a 87% yield. 
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 3.28 (t, 
3
JHH =8.50 Hz, 1H, H
2
); 3.44 (t, 
3
JHH =6.53 
Hz, 2H, H29); 3.30- 3.76 (m, 28H, H3-5, 6(1H), H8, H9, H11, H12, H13(1H), H14, H15, 
H16, H17, H18, H24, H25, H26, H27);3.79 (t, 
3
JHH =6.53 Hz, 2H, H28); 3.81-3.88 (m, 2H, 
H6(1H), H10); 3.90-4.07 (m, 1H, H13);3.90 (t, 
3
JHH =6.34 Hz, 2H, H23);3.96-4.04 (m, 1H, 
H13); 4.34-4.36 (m, 2H, H1, H7); 4.58 (t, 
3
JHH =6.34 Hz, 2H, H22); 4.62 (s, 2H, H19); 8.15 
(s, 1H, H21). 
 
13
C-NMR (δ CD3OD, 75 MHz) ppm: 30.27; 50.10; 60.42; 61.17; 63.54; 68.15; 68.59; 61.41; 
68.59; 68.70; 69.50; 69.60; 70.19; 70.40; 72.44; 73.28; 74.97; 75.75; 76.30; 79.67; 100.84 
(C7); 103.00 (C1); 124.66 (C21); 144.19 (C20). 
 
 
36 
 
Preparation of GA 5 
 
GA 5 was prepared with a 40% yield by alkylation of N-dimethyl-N-hexadecylamine with 
compound 24 according to the procedure described above for the preparation of GA1.  
 
1
H-NMR (δ CD3OD, 300 MHz) ppm: 0.88 (t, 
3
JHH =6.92 Hz, 3H, H47); 1.24-1.44 (m, 26H, 
H34, H35, H36, H37, H38, H39, H40, H41, H42, H43, H44, H45, H46); 1.70-1.83 (m, 2H, 
H33); 3.13 (s, 6H, H30, H31); 3.28 (t, 
3
JHH =8.50 Hz, 1H, H2); 3.30- 3.76 (m, 29H, H3-5, 
6(1H), H8, H9, H11, H12, H13(1H), H14, H15, H16, H17, H18, H24, H25, H26, H27, 
H29); 3.81-3.88 (m, 2H, H6(1H), 10); 3.90-4.07 (m, 1H, H13); 3.96-4.04 (m, 1H, H13); 
4.34-4.36 (m, 2H, H1, H7); 4.58 (t, 
3
JHH =6.34 Hz, 2H, H22); 4.62 (s, 2H, H19); 8.15 (s, 1H, 
H21). 
 
13
C-NMR (δ CD3OD, 100 MHz) ppm: 13.09 (C47); 22.32, 22.36, 26.07, 28.92, 29.10, 
29.23, 29.30, 29.39, 29.43, 31.70 (C33, C34, C35, C36, C37, C38, C39, C40, C41, C42, 
C43, C44, C45, C46); 50.05 (C22); 50.94 (C30, C31); 60.42; 61.18; 63.58; 64.36; 65.55; 
68.21; 68.96; 69.35; 69.95; 69.98; 70.00; 70.11; 70.04; 70.15; 70.21; 71.16; 73.43; 73.65; 
75.57; 76.63; 76.65; 79.38; 102.51 (C7); 103.8145 (C1); 124.41 (C21); 144.10 (C20). 
 
 
37 
 
 
Determination of the critical micellar concentration (cmc) of amphiphile 1 and 4 by 
conductivity measurements 
Conductivity measurements were carried out at 25 °C by adding known volumes of a GA 1 
or GA 4 stock solution (5×10
-1
 M and 8×10
-1
 M, respectively) to 30 mL of deionized water. 
Specific conductivity, K, of solutions was measured after thorough mixing and temperature 
equilibration at each addition. Values of K were plotted versus concentration. The error in 
the conductivity measurements was within ±0.1%. 
Determination of aggregates size by DLS 
Aqueous solutions of GA 1 or 4 (50 mM) in PBS were characterized by DLS at a scattering 
angle of 173° at 25 °C. The normalized intensity autocorrelation functions were measured at 
an angle of 173° at 25.0±0.1 °C. The autocorrelation functions were analyzed by using the 
cumulant fit. The first cumulant was used to obtain the apparent diffusion coefficients D of 
the particles, further converted into apparent hydrodynamic diameters, dh, by using the 
Stokes–Einstein equation dh= kBT/3π D ,where kBT is the thermal energy and  the solvent 
viscosity.  
Binding of 1 and 4 to fluorescent labeled ConA, FITC-ConA 
The affinity between FITC-ConA and GA 1 or 4 was investigated at 25 °C by steady-state 
fluorescence experiments (at 525 nm; ecc= 488 nm) according to a reported procedure
33
 
The fluorescence intensity of 2.5 mL of a solution containing 2.4 µg/mL of FITC-Con A 
and 3.2 µg/mL of glycogen in PBS was investigated as a function of the addition of small 
volumes of a 21.6 mM solution of amphiphile (1 or 4) in PBS. In a blank experiment the 
fluorescence intensity of 2.5 mL of a solution containing 2.4µg/mL of FITC-ConA (in the 
absence of glycogen) was investigated as a function of the addition of small volumes of a 
21.6 mM solution of amphiphile in PBS. 
 
 
 
 
 
                                                 
33 Lis H. et al.Chem. Rev., 1998, 98, 637 
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Results and Discussion 
In the synthetic activity of this thesis the synthetic possibility of creating a library of 
glycosylated amphiphiles, that could allow an extensive activity/correlation study on 
liposomes including them in the formulation, was explored. 
Each of the glycosylated amphiphiles prepared in this work is characterized by the presence 
of i) a carbohydrate residue (Chart 2.1) that should attribute specificity toward lectins, a 
peculiar class of sugar-binding proteins
33
, ii) a hydrophobic portion that should guarantee 
the anchorage to the lipid bilayer of a liposome, iii) an ammonium group that attributes the 
positive charge to the formulation, iv) a polyoxyethylenic spacer that should guarantee a 
good exposure of the sugar residue on the surface of liposomes.  
The specificity of the carbohydrate-lectin interactions has been exploited as strategy for 
drug delivery where either carbohydrates or lectins have been used as homing devices to 
target specific cells or tissues. 
In exploring the synthetic possibilities the variability of each of the portions of an 
ammonium salt based glycosilated amphiphile was explored, i.e. the sugar moiety, the 
hydrophilic spacer and the hydrophobic region. In fact, glucose was used for the preparation 
of amphiphiles 1, 2, 3 and 4 and lactose was used for amphiphile 5. A hydrophilic spacer of 
different length was exploited to link the sugar residue to the ammonium group. Finally 
different hydrophobic portions, i.e. a different number of hydrocarbon tails or hydrocarbon 
tails of different length were used. 
Amphiphiles 1-5 were synthesized according to the synthetic pathway described in Scheme 
2.1 and Scheme 2.2. 
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Scheme 2.1. Synthetic pattern for the preparation of GAs 1, 2 and 3. 
The key step of the convergent synthesis used for the preparation of the five amphiphiles is 
the Cu(I)-catalyzed “click” reaction that provides the linkage of azido-compound and the 
terminal alkyne with high yield and simple and mild reaction conditions
34
. The azido-
compound 11 was obtained starting from tetraethylene glycol by common steps and isolated 
by a relatively simple procedure
16
.
 
The alkyne 7 was obtained by the deacetylation of the 
commercial available tetra-O-Acetyl- -D-propargylglucopyranoside. The obtainment of the 
click adduct 12 in high yield was confirmed by the presence of triazolic signal at 8.15 ppm 
in the 
1
H NMR spectrum. Moreover, the 1,4-disubstitution of triazolic adduct was 
demonstrated by the presence of two correlation peaks of the triazolic proton with both 
adjacent methylenes at 4.59 and 4.64 ppm in the 
1
H-
1
H NMR NOESY spectrum. The 
alkylation of three tertiary amines differing for the hydrophobic tails, yielded GAs 1, 2 and 
3. Amphiphiles 4 and 5, characterized by a different hydrophilic spacer with respect to 1, 2 
                                                 
34 Kolb H. C. et al.Angew. Chem.Int. Ed., 2001, 40, 2004 
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and 3 were obtained by alkylating the same tertiary amine, N-hexadecyl-N,N-
dimethylamine, with a click adduct bearing the glucose and lactose moiety, respectively. 
 
 
Scheme 2.2. Synthetic pattern for the preparation of GAs 4 and 5. 
 
In these cases, the synthetic procedures that gave the corresponding alkynes were more 
complex with respect to those illustrated above because they required the formation of a O-
glycosidic bond. This aspect, that implies a higher number of synthetic steps, caused a 
decrease of the total yield. The alkyne 16 was obtained starting from D-glucopyranose and 
triethylene glycol following a reported procedure
35
. The -O-glucosidic compound 21 was 
obtained by reacting -peracetylatedglucopyranose 14 and compound 16 in the presence of 
                                                 
35 Michel O. et al. Langmuir, 2008, 24,12116 
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Et2O∙BF3. The formation of the glycosidic bond between peracetylatedlactose 17 and 16 
required a different synthetic approach because the reaction did not work in the presence of 
Et2O∙BF3. The obtainment of five different glycosylated amphiphiles indicated that the 
exploited synthetic procedure might allow the obtainment of a large library of glycosilated 
cationic amphiphiles. The interaction of the glycolipid included in the lipid bilayer of 
liposomes with the proper receptor involves a good exposure of the sugar residue on the 
surface of the liposomes. The introduction of two different hydrophilic spacers in the 
amphiphile molecules was explored to obtain GAs 1-3 characterized by the shorter spacer, 
and GAs 4 and 5 characterized by the longer one. GAs 1 and 4 differ only for the 
hydrophilic spacer, having the same sugar residue, i.e. glucose, and the same hydrophobic 
region, i.e. the hexadecyl tail. Therefore their aggregation properties were fully 
characterized in order to include them in liposome formulations and to investigate both 
experimentally and theoretically the binding of their formulations with Concanavalin A, 
Con A, a soy ben lectine specific for glucose used as a model compound in similar 
investigations
20
. 
Aggregating properties of Gas 1 and 4 
Krafft point and Krafft temperature of GAs 1 and 4 were evaluated as <4 °C because their 
20 mM aqueous solutions are completely transparent and stable at 4 °C. The plots of 
specific conductivity, K, versus the concentration of amphiphile 1 and 4 show two linear 
trends whose intersection at 1.0 X 10
-3 
M and 4.3  10
-3
 M, respectively defines the  cmcs
36
.  
The DLS analysis of solutions of GA 1 and 4 above their cmc indicated the presence of 
micelles characterized by hydrodynamic diameter of 6.1 nm and 5.8 nm, respectively. 
  
Binding of Gas 1 and 4 with ConA 
Before investigating the binding of the liposome formulations including 1 and 4 with Con A 
(next chapters), the binding of pure GA 1 or 4 with Con A was investigated by florescence 
experiments exploiting fluorescent labeled Con A, FITC-Con A. The fluorescence of FITC-
Con A is quenched upon complexation with multibranched polysaccharides of D-glucose 
such as glycogen, and restored by addition of monomeric D-glucose
37
. It was thus expected 
                                                 
36 Ananthapadmanabhan K. P. et al. Langmuir, 1985, 1, 352 
37 Sato K. et al. J. Anal. Bioanal. Chem., 2006, 384, 1297 
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that  GA 1 or 4 could displace glycogen, thus dequenching the fluorescence of FITC-Con A 
similarly to D-glucose. Therefore, the fluorescence emission spectrum of a FITC-ConA 
solution quenched by glycogen was investigated upon the addition of GA 1 and 4. The 
addition of small volumes of solutions of 1 and 4 restored the fluorescence of the protein as 
shown in Figure 2.1. The obtained results indicate that the glucose moiety of GA 1 and 4 
substantially show the same capability to displace glycogen and to bind with ConA.  
 
Figure 2.1. Fluorescence intensity increase observed 
upon the addition of GA 1 (blue squares) and GA 4 
(red circles) to a solution of FITC-Con A-glycogen 
conjugate in PBS buffer. Initial concentration of 
FITC-Con A is 2.4μg/mL; initial concentration of 
glycogen is 3.2μg/mL. 
 
In conclusion, the length of the polyoxyethylenic spacer has not a relevant influence on 
the aggregation properties of the amphiphiles and on their interaction with Con A. 
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Chapter 3 
 
Inclusion of glucosylated amphiphiles 1 and 4 in liposomes formulations 
This chapter deals with the physicochemical characterization of liposomes formulated with 
a natural phospholipid, DMPC, and glucosylated amphiphile, GA 1 or 4 at 9.5:0.5 and 9:1 
molar ratio. The size and the size distribution, the main transion temperature (Tm), the 
surface potential and the interaction with lectins were investigated by DLS, fluorescence 
and UV spectroscopic measurements. 
 
Experimental 
Instrumentation 
Steady-state fluorescence experiments were carried out on a Fluoromax-4 Horiba-Jobin 
Yvon spectrofluorimeter.  
The optical density (OD) and UV measurements were carried out on Cary 300 UV–vis 
double beam spectrophotometer (Varian Australia PTY Ltd., Mulgrave, Vic., Australia). 
DLS measurements were performed with a Malvern Nano-ZetaSizer spectrometer, equipped 
with a 5 mWHeNe laser (wavelength = 632.8 nm) and a digital logarithmic correlator.  
 
Materials 
2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was purchased from Avanti Polar 
Lipids (Alabaster, AL). 4-heptadecyl-7-hydroxycoumarin (HC), 6-
dodecanoyldimethylaminonaphthalene (Laurdan) Concanavalin A (ConA), from 
Canavalina ensiformis (Jack bean), glycogen, from bovine liver were purchased by Sigma-
Aldrich. 
 
Liposomes preparation 
Aqueous dispersions of DMPC/1(4) liposomes were prepared according to the procedure 
described by Hope et al.
38
 Lipid films were prepared on the inside wall of a round-bottom 
flask by evaporation of solution containing the proper amount of DMPC (dissolved in 
CHCl3) and 1 (4) (dissolved in MeOH) to obtain the desired molar percentage mixture. The 
                                                 
38 Hope M. J. et al. Reduction of Liposomes Size and Preparation of Unilamellar Vesicles by Extrusion 
Techniques in Liposome Technology, 2nd ed.; Gregoriadis, G. Ed. CRC Press: Boca Raton, FL, 1992, Vol.I, 
123-139 
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obtained lipid films were kept overnight under reduced pressure (0.4 mbar) and PBS was 
added to obtain a lipid dispersion of the desired concentration. The aqueous solutions were 
vortex-mixed and then freeze-thawed six times from liquid nitrogen to 40 °C. Lipid 
dispersions were then extruded (10 times) through a 100 nm polycarbonate membrane. 
 
Determination of aggregate size by DLS 
The mean diameter and size distribution of liposomes were measured by DLS. Liposomes 
1.25 mM in PBS were analyzed soon after preparation and after 48 hours. The normalized 
intensity autocorrelation functions were measured at an angle of 173° at 25.0±0.1 °C. The 
intensity size distribution of the liposomes was typically unimodal, therefore the 
autocorrelation function was analyzed according to the cumulant method. The 
autocorrelation functions were analyzed by using the cumulant fit. The first cumulants was 
used to obtain the apparent diffusion coefficients D of the particles, further converted into 
apparent hydrodynamic diameters, dh, by using the Stokes–Einstein relationship 
DTkd Bh 3 , where kBT is the thermal energy and  the solvent viscosity.  
 
Tm determination by fluorescence experiments. 
The phase transition temperature, Tm, of the liposome bilayer was determined by a 
spectrofluorimetric method  using Laurdan as a fluorescent probe highly sensitive to lipid 
phases. A mixed lipid film was prepared from a chloroform solution containing the proper 
amount of lipids (DMPC/1 (4) at 95:5 molar ratio) and a volume of a Laurdan 0.4 mM 
chloroform stock solution to obtain a 1 M Laurdan concentration and a 1 mM lipid 
concentration. Emission spectra ( ecc= 360 nm) were acquired as a function of temperature 
in the range 15–50 °C to determine the Tm of the formulation. Temperature was controlled 
by a circulating bath and the actual temperature was measured in the sample cuvette by a 
thermocouple. Excitation at 360 nm allows avoiding the photoselection of the probe 
molecules. The spectra were corrected for lamp intensity variations. The generalized 
polarization parameter (GP)
39
 was calculated by equation 3.1: 
 
GP = (IB- IR)/(IB+ IB)  3.1 
 
                                                 
39 Parasassi T. et al. Biophys. J., 1990, 57, 1179 
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where IB and IR are the fluorescence emission intensities corresponding to the emission 
maxima characteristic of Laurdan in the pure gel and liquid-crystalline phases, i.e. 440 nm 
in the gel phase and 490 nm in the liquid crystalline phase
40
. The transition temperature for 
the liposome preparation corresponds to the inflection point in the GP versus temperature 
plot. 
 
Tm determination by optical density (OD) measurement 
Thermal phase transition of mixed liposomes was determined from the temperature-
dependent changes of specific turbidity. The temperature scan, in the 20-35 °C range, was 
carried out at 260 nm at a 1 °C/min rate. Results were expressed in turbidity (OD) as a 
function of temperature. The Tm of the liposome formulation corresponds to the inflection 
point in the OD versus temperature plot. Measurements were made at 2.5 mM total lipid 
concentration in PBS. 
 
Determination of potential surface(ψ°) of DMPC/1 (95:5) liposome 
Surface potential was determined by an indirect method described in the literature that 
exploits the pH-sensitive fluorophore HC
41
. Liposomes were prepared as described above, 
in this case DMPC/1 (4), mixed films were prepared from a chloroform solution containing 
the proper amount of lipids and also a volume of a HC 10
-4
 M THF stock solution (to obtain 
after hydration of the lipid film a final 10
-4
 M HC concentration and a 1 mM lipid 
concentration). 
Fluorescence measurements of 5 mM liposome suspension of DMPC/1/HC (95/5/0.3) in 
PBS were performed by scanning the excitation wavelength between 300 and 400 nm, at an 
emission wavelength of 450 nm, varying the pH between 2 and 12 by addition of 
concentrated sodium hydroxide or hydrochloric acid. The dissociation degree of HC 
incorporated into liposomes was monitored by the ratio of the excitation fluorescence 
intensities at 380 nm and 330 nm (pH independent isosbestic point). pKa of HC in the 
liposome bilayer and consequently, the surface potential (ψ°) was obtained by the plot of 
I380/I330 ratio as a function of pH. 
                                                 
40 Parasassi T. et al.  J. Fluoresc., 1998,  8(4), 365 
41 Zuidan, N. J. et al. Biochim. Biophys. Acta,1997, 1329, 211 
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Agglutination detection by optical density measurement. 
The agglutination of functionalized liposomes in the presence of ConA was determined 
from the time-dependent changes of specific turbidity of a 1 mL sample of 0.8 mM 
DMPC/GA (95:5) liposomes in PBS in a 1 cm quartz cell upon addition of Con A (0.33 
mg/mL final concentration) in PBS. Scan was carried out at 525 nm immediately after 
mixing and every minute till 5 hours. 
 
Agglutination detection by DLS measurement. 
The agglutination of functionalized liposomes in the presence of ConA was determined 
from the time-dependent changes of size distribution in a 1 mL sample of 0.8 mM DMPC/1 
or DMPC/4  (95:5) liposomes in PBS upon addition of Con A (0.33 mg/mL final 
concentration) in PBS. Scan was carried out immediately after mixing and agglutination has 
been followed for 5 hours.  
  
Results and discussion 
Liposomes size and stability 
Liposome size can vary from very small to large vesicles and size is a critical parameter in 
determining liposome circulation half-life because it affects clearance by the 
reticuloendothelial systems (RES). In fact, small liposomes are opsonized less rapidly and to 
a lower extent compared to large liposomes. 
The size of DMPC/1 (4) liposomes (at 1.25 mM concentration) was determined by DLS 
measurements. The results obtained by DLS analysis are reported in Table 3.1. Soon after 
extrusion and after 24 hours the presence of a stable monomodal distribution (confirmed by 
the low value of polydispersity index, PDI) of liposomes characterized by a hydrodynamic 
diameter in agreement with extrusion protocol were observed only for the 95:5 formulation, 
whereas a polydistribution was found for the 90:10 formulations. The intensity of light 
scattering is directly proportional to the sixth power of the particle radius and to the square 
of the mass of the aggregates, therefore though a peak corresponding to small aggregates 
can show a low intensity, this population could also be the major one, or very abundant. In 
the case of 9:1 DMPC/1 (4) liposomes the presence of a second population of small 
aggregates, whose abundance significantly increases after 24 hours, indicates that also a 
relatively low amount (10%) of glucosylated amphiphile 1 or 4 strongly destabilizes the 
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lipid bilayer due probably to a detergent effect. Thus, only the 95/5 DMPC/1(4) 
formulations were selected for further investigations. 
Table 3.1. Hydrodynamic diameter of the DMPC/GA liposomes obtained from dynamic light 
scattering measurements at 25°C. 
 
Formulations Size, nm t 0 
(Peak area 
Intensity,%) 
 
PDI t 0 STDV, 
nm t 0 
Size, nm  t 24 h 
(Peak area 
Intensity, %) 
 
PDI 
t 24 h 
STDV 
t 24 h 
DMPC/1 
95/5 
95 0.173 ±23 106 0.164 ±20 
DMPC/1 
90/10 
245, 48 
(90, 10) 
0,364 ±30 230,50 0,370 ±25 
DMPC/4 
95/5 
110 
 
0.05 ±15 115 0.07 ±13 
DMPC/4 
90/10 
135, 24
* 
(95, 5) 
0.26 ±20 166, 30
* 
(77, 33) 
0.33 ±18 
1 
 
6 0.06 ±2 10 0.05 ±2 
4 
 
6 0.002 ±3 8 0.007 ±2 
 
Main transition temperature (Tm) 
Lipids are characterized at a certain temperature, Tm, by a phase transition which involves 
substantial changes in the organization and motion of the fatty acyl chains within the 
bilayer. Below the Tm lipids are in a rigid, well-ordered arrangement (“solid” gel-like 
phase); above the Tm are in a liquid-crystalline (“fluid”) phase (Figure 3.1)42. 
 
 
Figure 3.1. Schematic representation of the lipid 
arrangement in a planar bilayer below and above 
the main lamellar chain-melting phase transition 
temperature, i.e. the Tm.  
 
                                                 
42 Walde P. et al. Biomol. Bioeng., 2001 18(172), 143  
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When a membrane is heated through the Tm the surface area increases and the thickness of 
the lipid bilayer decreases as the membrane goes through a phase transition. The mobility of 
the lipid chains increases dramatically. This is the reason why mechanical treatments of 
lipid vesicles have to be carried out above Tm, in the fluid state of the membranes. 
Below the Tm, the saturated hydrophobic chains exist predominately in a rigid, extended all 
trans conformation, similar to their crystalline state. As a result, the surface area per lipid is 
minimal and the bilayer thickness is maximal. Above the Tm, the chains are rather 
disordered with a number of gauche conformations in the hydrocarbon chains, that make the 
lipid bilayer fluid (mechanically treatable) and characterized by increased lateral and 
rotational lipid diffusion rather similar to a liquid; as a result, the surface area per lipid 
increases and the bilayer thickness decreases by 10 to 15%. Tm value depends to some 
extent on the curvature of the bilayer and on the experimental conditions, in particular if the 
amphiphiles have polar head groups that can undergo protonation/deprotonation.  
The Tm of the 95:5 DMPC/1 and DMPC/4 liposome formulations were measured by both 
fluorescence and turbdimetric measurements. It is known that the fluorescence properties of 
a particular membrane probe, i.e Laurdan, included in a lipid bilayer, can give information 
on the Tm of the lipid bilayer
43
. In a lipid membrane Laurdan does not have specific affinity 
towards any phospholipid head group and distributes equally, at the level of glycerol 
backbone, between the gel and the liquid-crystalline phases, however, it displays a phase-
dependent emission spectral shift, from 440 nm in the gel to 490 nm in the liquid-crystalline 
phase, due to the solvent dipolar relaxation phenomenon
39
. The red shift depends on the 
water concentration and mobility close to the Laurdan naphthalene moiety, and is observed 
only in the liquid crystalline phase, because water mobility is significantly slower in the 
tightly packed gel phase, and the dipoles cannot reorient during the Laurdan excited state
40
. 
Thus, the value of GP (Experimental part) is related to water penetration and to the phase 
state of the lipid membrane.  
The turbidimetric method of analysis of liposome suspensions is based on measuring 
temperature-dependent sample turbidity, determined as optical density (OD) at 260 nm, 
where the absorption of the sample is negligible; hence, the light attenuation by the particle 
suspension is only due to scattering, and variations in phase transition depend on the 
geometric and physical parameters of liposomes, such as dimensions and refractive indexes 
of the assemblies.  
                                                 
43 Aleandri S. et al. Soft Matter, 2012, 8, 5904  
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The results obtained by fluorescence and turbidity measurements are reported in Table 3.2. 
The values obtained by the two techniques are in optimal agreement and are very close to 
each other and to the Tm of DMPC, indicating that the presence of 5% of both 1 or 4 does 
not induce any significant change in the organization of the lipid bilayer of DMPC. This 
result is not surprising because the two GA bear the same alkyl chain and the main 
transition, as explained above, occurs in the hydrophobic region of the lipid bilayer. 
 
Table 3.2. Tm values of DMPC/1(4) measured by both 
fluorescence and turbdimetric measurements. Uncertainty 
in determination is 0.5 °C. 
 
 Tm (°C) 
Fluorescence  
Tm (°C) 
OD 
DMPC 24.2 24.1 
DMPC/1 95/5 24.5 24.2 
DMPC/4 95/5 24.5 24.3 
 
Potential Surface (ψ°) 
The potential at the interface between the lipid bilayer and adjacent electrolyte solution is 
defined as the surface potential, ψ0; this potential is due to the fixed charges within or 
attached to the membrane phase (with the Stern layer). The measurement of surface 
potential can be made through the determination of a so-called potential-determining ion. 
The extent of the association of a potential determining ion depends on its concentration in 
the bulk because its electrochemical potential must be the same in both phases (i.e. at the 
surface and in the bulk). In proteins, biological materials and metal oxides, H3O
+
 is 
frequently a potential-determining ion because of the pH dependence on the degree of disso-
ciation of acid or basic groups. It seems reasonable to consider that potential-determining 
ions completely leave the solution phase and become desolvated and in tight chemical 
association with the membrane surface. The surface potentials are not usually readily 
measurable with electrodes due to the thickness of the membrane phase. Here we obtained 
surface potential by the use of the lipophilic, pH-sensitive fluorophore HC, following a 
procedure described in the literature
41
. 
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 Its fluorophore is the hydroxycoumarin moiety, which is a weak acid. At pH < pKa the 
maximal fluorescence intensity is found at an excitation wavelength of ~ 320 nm, and at pH 
> pKa the excitation maximum is shifted to the wavelength of ~ 380 nm. The fluorescence 
intensity at the excitation wavelength of 330 nm is the pH-independent isosbestic point, 
which reflects the actual level of the fluorophore present in the lipid assembly. In Figure 
3.3a excitation fluorescence spectra of HC included in DMPC liposomes at low and high pH 
value are reported; in Figure 3.3b excitation fluorescence spectra registered in the titration 
of HC included in DMPC liposomes are reported. Therefore, the dissociation degree of HC 
incorporated into the mixed DMPA/GA liposomes can be monitored by the ratio of the 
excitation fluorescence intensities at 380 and 330 nm (380 nm/330 nm) as a function of the 
pH ( see figure 3.2). 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.  Excitation fluorescence intensities at 380 and 330 nm (I380 /I330) as a 
function of the pH for the 95:5 DMPC/1. 
 
 (nm)
300 320 340 360 380 400
F
lu
o
re
sc
en
ce
 i
n
te
n
si
ty
 (
a.
u
.)
0
50
100
150
200
250
300
 (nm)
300 320 340 360 380 400
0
50
100
150
200
250
300 ba
Figure 3.3. a) Excitation fluorescence spectra of HC included in DMPC liposomes at low pH 
value (black trace) and high pH value (red trace); b) Excitation fluorescence spectra registered 
in the titration of HC included in DMPC liposomes  
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Proton binding to a molecule which is present at the water/lipid interface, such as HC, can 
be described by
44
  
 
pKa = pKH + ΔpKpol + ΔpKe1
 
 
where pKH is the proton association constant, ΔpKpol is the shift in pKa due to a change in 
surface polarity (dielectric constant), and ΔpKe1 is the shift in pKa due to a change in surface 
potential. We assume that DMPC liposomes are neutral throughout the pH range used in this 
study. Therefore, ΔpKel of HC in charged liposomal membranes can be estimated by taking 
the pKa of HC in DMPC liposomes as a neutral reference, assuming that there is no change 
in surface polarity (see equation 3.2 ). The value of ΔpKel is then used to calculate the 
electrical surface potential at the location of the chromophore in the charged membranes, 
ψ0
HC
 (V), by conversion and rearrangement of Boltzmann equation:  
 
ψ0
HC
 = - ΔpKel kTln10/e = - (pKa
charged
 – pKa
neutral
)KBTln10/e 
 
where KB is the Boltzmann constant, T is the absolute temperature, e is the electron charge 
and pKa
charged
 – pKa
neutral
 are the pKa in charged bilayers and in neutral DMPC bilayers 
respectively.  
95:5 DMPC/1 and DMPC/4 formulations were characterized, as expected, by a positive 
value of potential surface ψ° (23±6 mV and 24±3 mV, respectively), due to the exposure of 
ammonium groups on vesicles surface. Also in this case, the obtained values are very 
similar to each other and this could have been expected  considering that the two molecules 
feature the same polar headgroup that is probably located in the same region of the bilayer. 
 
Interaction of amphiphile 1 and 4 with Con A (agglutination assay)  
In order to evaluate the interaction of the sugar residues on the surface of liposomes with 
Con A and to investigate possible differences due to the different length of hydrophilic 
spacer turbidity and DLS measurements were performed. In fact, the interaction of Con A 
with sugar decorated liposomes results in aggregation of vesicles, known as agglutination, 
                                                 
44 Tatulian A.S. et al. Phospholipids Handbook, 1993, 551 
3.2 
3.3 
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due to the presence of multiple binding sites for carbohydrates on the protein (multivalent 
binding), and agglutination can be monitored by turbidity and DLS. 
 
OD measurements.  
In the case of 95:5 DMPC/4 liposomes changes of OD were observed upon the addition of 
Con A, and vesicle precipitation occurred in ~100 minutes. This result clearly indicates that 
agglutination took place (Figure 3.4, red line). On the other hand, when the same 
experiment was carried out on 95:5 DMPC/1 liposomes an increase of the OD value was 
observed, however precipitation did not occur (Figure 3.4, blue line). This results suggests 
that also in this case agglutination occurs, but the phenomenon is slower than in the case of 
DMPC/4 liposomes. In the case of DMPC liposomes, i.e. devoid of GA, the addition of Con 
A also induced agglutination, as reported in the literature
45 
however OD changes were not 
detected for at least 4 hours and precipitation was observed only after 24 hours. In the 
absence of Con A, neither OD changes nor precipitation were observed. Thus, the presence 
of 5% of the amphiphile 1 or 4 strongly affects the kinetic of the interaction of liposomes 
with Con A, further the efficacy of interaction with Con A depends on the length of the 
hydrophilic spacer, being more efficient in the case of GA 4. This suggests that in the case 
of DMPC/4 vesicles the sugar moiety is more exposed to the bulk and, as a consequence, 
more accessible to the lectin. 
DLS measurements  
The results obtained by DLS measurements are reported in Figure 3.5. In the presence of 
DMPC/4 liposomes agglutination and precipitation occured, in good agreement with the 
results obtained by turbidity measurements. On the other hand, when the same experiment 
was carried out on DMPC/1 liposomes neither agglutination or precipitation was observed. 
However this apparent discrepancy with the results obtained by turbidity measurements 
could be due to the low concentration conditions. Therefore DLS results are in good 
agreement with OD measurements. 
 
 
 
                                                 
45 Engel A. et al. Journal of Pharmaceutical Sciences, 2003, 92, 2229 
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Figure 3.4. Turbidity increase observed upon the addition of Con A to a 
suspension of 95:5 DMPC/GA vesicles in PBS (GA 4 red line; GA 1 blue line). 
Con A concentration is 0.33 mg/mL; total lipids concentration is 0.8 mM. 
 
Figure 3.5. Size changes increase observed upon the addition of Con A to 
suspensions of  95:5 DMPC/GA vesicles (GA 4 red circles; GA 1 blue circles, 
plotted in a different scale in the upper right).in PBS. Con A concentration is 
0.33 mg/mL; total lipids concentration is 0.8 mM. 
 
Summarizing, the presence of 5% of the GA in liposomes does not alter the 
physicochemical properties of the lipid bilayer of DMPC liposomes, whereas when the its 
percentage increases it has a strong perturbing effect. DMPC/4 liposomes were shown to 
interact with con A also in the dilute conditions of DLS experiments, thus demonstrating a 
better efficacy of interaction with respect to DMPC/1 liposomes. It is clear that the length of 
the polyoxyethylenic spacer has a fundamental role on the exposure of the sugar moiety on 
the surface of liposomes and hence on the binding of glycosylated liposomes to lectins. 
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Chapter 4 
 
Investigation of the interaction of Concanavalin A with glycosylated liposomes 
by molecular dynamics simulation. 
This chapter reports on the theoretical investigation of the interaction of ConA with lipid 
bilayers composed of DMPC and GA 1 or 4 by molecular dynamics calculations.  
Molecular dynamics is a branch of computational chemistry that allows studying, through 
simulations, the time evolution of molecular system models. These are based on a 
simplified description of atomic interactions, obtained through the use of a set of functions 
of potential energy, defined as force field, parameterized by experimental data or obtained 
from results of quantomechanical calculations. Forces acting on the particles that compose 
the system derive from molecular potential functions, and by applying the principles of 
classical mechanics it is possible to obtain the evolution of the system as a function of 
time, named trajectory. The trajectories obtained are used to calculate the structural and 
thermodynamic properties of the studied system on the basis of the ergodic hypothesis that 
establishes the equivalence of the time average, for long periods of simulation, with 
statistical average of the microstates that characterize the system. 
The first molecular dynamics simulation was reported by Alder and Wainwright
46
 who 
studied the dynamics of an assembly of hard spheres to simulate a crystal/liquid system. 
With the advent of faster computers and of high-level programming languages, it was 
possible to simulate much more complex molecular systems such as liquid water
47
, 
alkanes
48
 and small proteins
49
. Moreover, molecular dynamics has been used successfully 
to simulate molecular aggregates of amphiphilic molecules such as micelles and lipid 
membranes, thus obtaining information on some biological phenomena
50
. The first 
molecular dynamics simulation of a lipid bilayer, performed by van der Ploeg and 
Berendsen
51
 in 1982, involved a system of 32 dodecanoate molecules arranged in a bilayer. 
With the increase of computational power, it has been possible to simulate systems with a 
higher extent of complexity. Several studies concerned peptides at the membrane/water 
                                                 
46 Alder, B. J. et al. J. Chem. Phys., 1957, 27, 1208  
47 Rahman, A. et al. J. Chem. Phys., 1971, 55, 3336  
48 Ryckaert, J. et al. Chem. Phys. Lett., 1975, 30, 123  
49 McCammon, J. et al. Nature, 1977, 267, 585  
50 Lookman T. et al. Biochemistry, 21, 1982,5593 
51 van der Ploeg, P. et al. J. Chem. Phys., 1982, 76, 3271  
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interface
52
, the formation of pores and peptides channels in lipid bilayers
53
, the interaction 
of proteins
54
, medicinal plant extracts and drugs
55
 with lipid membranes. At present, the 
accuracy of these techniques gives the possibility of analyzing and studying the binding of 
a protein with a ligand also considering the role of the solvent. An example is the paper by 
Kadirvelraj et al.
32
 that reports on the role of water molecules in the binding of Con A with 
a trimannoside saccharide ligand. It was shown that along all the simulation a number of 
water molecules remained in the lectin binding site with an active role in the binding. 
Recently it has been possible to simulate very complex systems involving a very large 
number of atoms by the coarse-grain method. In this method groups of atoms are 
assembled into beads to reduce the number of degrees of freedom, thus reducing the 
complexity and length of simulation. Though the obtained description is not atomistic, 
however this method gives valuable information on very complex systems such as liquid 
crystals
56
 and cell membranes
57
. Another valuable methodology that allows simulating 
very complex and large systems is the metadynamics. Metadynamics is a powerful 
algorithm that can be used both for reconstructing the free energy and for accelerating the 
sampling of rare events in systems described by complex Hamiltonians, at the classical or 
at the quantum level. In the algorithm the normal evolution of the system is based on a 
history-dependent potential constructed as a sum of Gaussians centered along the trajectory 
followed by a suitably chosen set of collective variables. The sum of Gaussians is 
exploited for reconstructing iteratively an estimation of the free energy and forcing the 
system to escape from local minima
58
.   
In this work the simulation of the membrane/protein systems was carried out at the 
atomistic level on a preassembled lipid bilayer embedded in water as requested for such a 
system. In fact, the molecular dynamic simulation of such a complex system, involving a 
large number of lipid and water molecules, requires a preassembled lipid bilayer because, 
due to computational times and costs, it is not possible to start from a random 
configuration.  
                                                 
52 Bernèche, S. et al. Biophys. J., 1998, 75, 1603 
53 Tieleman, D. P. et al. Biophys. J., 1998, 74, 2786 
54 Lumb C. N. et al. Biophysical Journal, 2013,104, 613 
55 Telenius J. et al. FEBS Journal 2013, 280, 2785 
56 Wang Y. et al. Acc. Chem. Res., 2007, 40(11), 1193 
57 SanSom M.S.P. et al. J. Chem. Phys., 2004, 121, 11942 
58 Laio A. et al. Rep. Prog. Phys., 2008, 71, 126601  
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Further, before the molecular dynamics investigation of the two DMPC/GA systems it was 
necessary to analyze, through a docking procedure, the binding of the saccharidic residues 
with the protein. In fact, the docking procedure allows a quite accurate prediction of the 
binding modes of a small molecule (ligand) with a large protein. Molecular dynamic 
simulation and docking procedure both required an accurate choice of force fields. 
The report on the simulation carried out on our lipid/protein systems will be preceded by a 
brief description of the basic principles underlying the adopted methodology to facilitate 
the reading to people who are not acquainted with theoretical chemistry.  
 
Docking: basic principles 
The molecular modeling prediction by the docking method involves a protocol that 
consists of two fundamental steps, i) a search strategy and ii) a scoring function.  
The search strategy makes use of a search algorithm and can generate a number of 
configurations that include the experimentally determined binding mode and all the 
possible binding modes of the ligand with the receptor. All six degrees of translational and 
rotational freedom of the ligand are explored along with the internal conformational 
degrees of freedom of both the ligand and the protein. Therefore, to reduce the complexity 
and size of calculation, it is necessary to apply constraints, restraints and approximations 
as, for example, that of treating the ligand and target as rigid bodies with the exploration of 
the only six degrees of translational and rotational freedom or, that of considering only the 
conformational space of the ligand by assuming a rigid receptor throughout the docking 
protocol.  
The scoring function makes use of the searching algorithm and allows distinguishing the 
experimental binding modes from all other explored modes. At present, it is possible to use 
the scoring function by two different approaches. In the first approach the full scoring 
function is used to set a protein ligand conformation, then the whole system is modified by 
the search algorithm, and finally the same scoring function is applied again to set the new 
structure. The alternative approach consists in using a two stage scoring function in which, 
first, a reduced function is used to direct the search strategy and then a more rigorous 
scoring function is used to rank the resulting structures. Currently there are different 
methods for docking studies, the principal techniques are: molecular dynamics, Monte 
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Carlo methods, genetic algorithms, fragment-based methods, distance geometry methods, 
tabu searches and systematic searches
59
.  
- Molecular dynamics (MD). The employment of standard MD to find the global 
minimum energy of a docked complex involves the calculation of solutions to 
Newton’s equations of motion. The main problem linked to this method is that often an 
MD trajectory will become trapped in a local minimum and will not be able to step 
over high energy conformational barriers and so the quality of the results is strictly 
dependent on the starting conformation of the system. 
- Monte Carlo (MC) methods are among the most established and widely used stochastic 
optimization techniques. The advantages of the MC technique are that i) a simple 
energy function can be used which does not require derivative information and ii) 
energy barriers can simply be stepped over. The standard MC method involves 
applying random Cartesian moves to the system and accepting or rejecting the move 
based on a Boltzmann probability. 
- Genetic algorithms. The essence of a genetic algorithm is the evolution of a population 
of possible solutions via genetic operators (mutations, crossovers and migrations) to a 
final population, optimizing a predefined fitness function. For this reason the genetic 
algorithm methods require the generation of an initial population whereas conventional 
MC and MD require a single starting structure in their standard implementation. 
AutoDock4
60
 is a program that uses a genetic algorithm as a global optimizer combined 
with energy minimization as a local search method. In AutoDock4, used in this work, 
the fundamental point is that the ligand is flexible and the receptor is rigid and 
represented as a grid. The genetic algorithm uses two point crossover and mutation 
operators. For each new population a user determined fraction undergoes a local search 
procedure using a random mutation operator where the step size is adjusted to give an 
appropriate acceptance ratio. The fitness function involves five terms i) a Lennard-
Jones 12-6 dispersion/repulsion term; ii) a directional 12-10 hydrogen bond term; iii) a 
coulombic electrostatic potential; iv) a term proportional to the number of sp3 bonds in 
the ligand to consider unfavourable entropy of ligand binding due to the restriction of 
                                                 
59 Taylor R.D. et al. Journal of Computer-Aided Molecular Design, 2002, 16, 151 
60 Morris G.M. et al. J. Comput. Chem., 2009, 16, 2785 
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conformational degrees of freedom; and v) a desolvation term. This scoring function is 
based loosely on the AMBER force field from which protein and ligand parameters are 
taken. Judson et al.
61
 were among the first to report the application of a genetic 
algorithm to the docking method. The method was tested by docking a protected 
tripeptide, Cbz-Gly-[P(O)OH]-Leu-Leu, into thermolysin and it produced 
conformations which were close to the experimental binding mode. In the last ten years 
the application of this method to protein/ligand was used also to carbohydrates-protein 
studies. An example concerns the work by Agostino et al.
62
 who investigated the 
application of molecular docking to carbohydrate–lectin recognition processes. 
Specifically they considered 15 different combinations of lectins (galectins, DC-SIGN, 
langerin, and SP-D) and ligands (single or polycarbohydrates based on mannose, 
glucose, galactose and fucose) whose crystal structures (as protein/ligand complexes) 
were available in high quality. Their results demonstrated that docking algorithms can 
identify the correct binding modes.  
- Fragment-based methods. The logic of fragment based docking methods can be 
described in sequence as i) dividing the ligand into separate portions or fragments, ii) 
docking the fragments, iii) linking of fragments. These methods require subjective 
decisions on the importance of the various functional groups in the ligand, which can 
result in the omission of possible solutions, due to assumptions made about the 
potential energy landscape. Furthermore, a judicious choice of base fragment is 
essential for these methods, and can significantly affect the quality of the results.  
- Distance geometry methods determine the binding modes between protein and ligand 
considering only hydrogen bonding. This method samples the conformational space 
identifying possible binding modes that are then used to direct an embedding 
algorithm. 
- Tabu searches. PRO_LEADS is a docking algorithm that may be described as a 
stochastic evolution of the system using a tabu search with a generalized scoring 
function, ChemScore. An initial random ligand conformation is generated (referred to 
as the current solution) and then scored. Random moves are then applied to the ligand 
to generate a population of solutions (typically 100 solutions). These solutions are then 
                                                 
61 Judson R. S. et al. Mol. Struct.: Theochem., 1994, 308, 191 
62 Agostino M. et al. Frontiers in Immunology, 2011, 2,1 
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scored and ranked in ascending order. The highest rank solution is then accepted as the 
new current solution (assuming it is the lowest energy so far). A new random 
population is then generated from this new current solution, and the process is repeated 
for a user-defined number of iterations. However, to ensure diversity of the current 
solution a tabu list is used. This list stores the orientations of the last 25 current 
solutions. If the lowest energy solution from the ranked population is the lowest energy 
so far, it is always accepted as the new current solution.  
- Systematic searches. EUDOC is a systematic search of rigid body rotations and 
translations of a rigid ligand within a rigid active site. It is based on a previous 
program, SYSDOC, that uses the fast affine transformation to perform the systematic 
search. The intermolecular energy is calculated by the AMBER-AA force field with a 
distance dependent dielectric.  
- Multiple method algorithms. Multiple method algorithms involve the combination of 
different docking techniques into a single strategy. In this method, that increase the 
effectiveness of a docking protocol, a two steps strategy is adopted in which an initial 
computationally inexpensive method is used, followed by a time consuming yet more 
accurate method to generate a final docking solution. 
 
Molecular Dynamic Simulation: basic principles 
Molecular dynamics, as all computational techniques, is subject to assumptions and 
approximations that reduce the accuracy of simulation, thus it is necessary to know and to 
evaluate the limits of the used computational technique in order to avoid overestimation of 
the model and hence of the obtained results. The key issues to be considered in molecular 
dynamics simulation are i) the space phase size accessible to the system and ii) the 
accuracy of the molecular model used in the simulation of the system. An actually 
achievable efficient sampling of space phases in short periods of simulation can be 
obtained by introducing approximations that reduces the degrees of freedom of the system.  
Concerning the accuracy of the force field, it is possible to assume that the motion of 
atoms can be sufficiently described by the laws of classic mechanics, if we exclude 
chemical reactions, systems at low temperature or the motion of hydrogen atoms.  
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The force field
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A molecular dynamic simulation involves the integration of Newton's motion equations 
that, for a system of interacting particles, is described by equation 4.1.  
i
i
im F
r
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2
t
   4.1 
where ri is the position of the particle i, and Fi is the force acting on it, that for a 
conservative system is equal to the derivative of the potential energy with respect to the 
position (equation 4.2) 
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The function V(ri) represents the force field which the system particles are subjected to, 
and which all motions depend on. An example of a potential function used in many 
programs of molecular dynamics simulations of protein/lipid bilayer systems is reported as 
equation 4.3.  
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The first term of equation 4.3 refers to the bond deformation energy and involves a 
harmonic potential, in which b0 represents the bond length that corresponds to a minimum 
of energy, and kb is the force constant. The second term is related to bond angle 
deformation energy, it also involves a harmonic function where 0 is the angle 
corresponding to the minimum energy value, and k  is the force constant. The third and 
the fourth terms of the equation refer to the dihedral angles (improper and proper).  The 
improper dihedral angles are introduced to correct the artifacts resulting from the 
deformation of planar geometries. In most molecular dynamic programs the hydrogen 
atoms are “fused” to the carbon atom to which they are linked. In other words, the carbon 
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atom does not keep its characteristics and is replaced by a pseudo atom (united atoms) that 
takes into account the incorporation of hydrogen atoms.  
 
 
 
 
 
 
 
 
 
The use of these pseudo atoms has the advantage, compared to the explicit treatment, to 
reduce computation time (motions of stretching of the hydrogen atoms are eliminated and 
thus it is possible to use a longer time step of integration; further, the choice of pseudo 
atoms also reduces the interactions between non-related atoms). The disadvantage of this 
approximation concerns the cases of chiral carbon atoms linked to a hydrogen atom 
because the inversion of configuration could occur during the simulation. Different types 
of functions are used to describe the torsional energy of proper dihedral angles; the 
function reported in equation 4.3 is one of the most commonly used. In the simulation of 
alkanes or of molecules with long alkyl chains (for example in micellar systems or lipid 
bilayers) the function of Ryckaert-Bellemans (equation 4.4, where ) is frequently 
used.
5 
This function allows obtaining a distribution of trans/gauche conformations of alkyl 
chains in optimal agreement with experimental data. Figure 4.1 describes the Ryckaert-
Bellemans function versus the dihedral angle. 
 
                                          
 
Figure 4.1. Ryckaert-Bellemans potential 
energy graphic for dihedral angles in alkyl 
chain. 
5
)cos()(
n
n
nijkldiedri CV 4.4 
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The last term of the equation 4.3 takes into account two-body interactions between not 
covalently bound atoms, i.e. van der Waals interactions and Coulombic interaction 
between i and j atoms having respectively qi and qj charges. The van der Waals interactions 
can be expressed by using different kinds of functions and equation 4.3 uses the function of 
Lennard-Jones. In the case of atoms separated by three covalent bonds the parameters of 
Lennard-Jones are suitably reduced to avoid the strong repulsions due to short distances. 
Others functions of force field involve mixed terms for the description of the coupled 
motions such as the deformation of the bond length and bond angle. The parameterization 
of the force fields, namely the definition of force constants and equilibrium values for the 
various terms, can be obtained by two different approaches. The first approach obtains the 
parameters from ab initio calculations performed on small molecules characterized by 
structural similarities with the simulated molecular system. Alternatively, the parameters 
can be obtained by an empirical approach, such as the parameterization of the force field 
based on the use of experimental data from X-ray crystal structures, spectroscopic analysis 
results, energy of vaporization, solvation free energies and NMR data. In molecular 
dynamics simulations a large portion of the computing time is employed to calculate the 
non-bonding interactions between atoms. Actually, while for the binding interactions the 
calculation time is proportional to the number of N atoms of the system, the calculation 
time for the non-bonding interactions is proportional to N
2
. Therefore, the simulation time 
and the size of the system will be strongly influenced by the non-bonding interaction 
calculation speed. The simplest method to make quick calculation of non-bonding 
interactions, is applying the cutoff method to non-bonding interactions. This consists in 
calculating the interactions between atoms that are not covalently linked only for those that 
are located inside a sphere of a cutoff radius (Rc). The introduction of a cutoff radius is 
useful for short-range interactions, those whose magnitude decreases rapidly as a function 
of the increase of distance between the interacting groups or interacting atoms (such as van 
der Waals interactions). Electrostatic interactions are treated in molecular mechanics by 
pairwise calculation using the Coulomb law. However, also in this case with the increasing 
size of the involved systems, and especially with the inclusion of explicit water molecules, 
the calculation of all possible interactions would take more than 90% of computational 
time and would make simulations unfeasible. One possibility to overcome this problem, as 
seen above for short-range interactions, is truncating the forces at a certain distance 
(cutoff). However in this case the cutoff introduces significant nonphysical effects 
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especially at and also beyond the cutoff distance. Several methods of avoiding these 
artifacts have been developed. A method that is used for uncharged molecular systems 
though composed by atoms with partial charges, involves the transformation of the 
electrostatic interactions into dipolar interactions using the concept of charge groups. 
Neighboring atoms in the molecule are grouped in such a way that the group has zero net 
charge, so that for long distances the sum of the contributions of monopole (r
-1
) between 
the various pairs of atoms is zero, and the only contribution is the multipole interaction (r
-n
, 
n  3). For example in the GROMOS
64
 force field the asparagine aminoacid is splitted into 
three different charge groups (Figure 4.2). One group is formed by the amide nitrogen and 
its hydrogen proton, another group is formed by the carbon atom and the carbonilic 
oxygen, finally the last group is formed by the lateral residue. 
 
 
 
  
 
 
 
 
 
 
 
A different method involves the introduction of the particle mesh Ewald technique
65
, 
which is able to run stable simulations also on highly charged systems as for example 
nucleic acids. Force fields commonly used in molecular dynamics simulations of 
biomolecular systems such as proteins, carbohydrates and nucleic acids, are AMBER
66
, 
CHARMM
67
, GROMOS
68
 and OPLS
69
.  
                                                 
64 Biomolecular Simulation: The GROMOS96 Manual and User Guide Vdf Hochshulverlag AG an der ETH 
Zürich, Zürich 1996 
65 Essmann U. et al. J. Chem. Phys., 1995, 103, 8577 
66 Cornell W. D. et al. J. Am. Chem. Soc., 1995, 117, 5179 
67 MacKerell A. D. et al. J. Phys. Chem. B, 1998, 102, 3586 
68 Scott W. R. P. et al. J. Phys. Chem. A, 1999, 103, 3596 
69 Jorgensen W. L. et al. J. Am. Chem. Soc., 1996, 118, 11225 
Figure 4.2. Charge groups used in 
GROMOS for asparagine aminoacid. 
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All of these force fields started out as united-atom approaches and recently AMBER, 
CHARMM and OPLS (OPLS-AA) have moved to an all-atom (AA) description. Only 
GROMOS keeps the united-atoms approach. 
At present, two force fields are commonly used in the simulation of lipids and phosholipids 
: one is part of CHARMM force field and the other one, introduced by Berger
70
, combines 
the GROMOS87 bonding parameters (bonds, angles, dihedral angles) with the Ryckaert-
Bellemans potential for the hydrocarbon chains and the OPLS
71
 (united-atoms) parameters 
for the Lennard-Jones interactions. Both of these force fields reproduce reasonably well the 
available experimental data of the structure and dynamics of lipid bilayers
72
, however the 
Berger force field has the advantage of a low computational cost due to the use of united-
atoms scheme. 
The presence in a system of different types of complex systems such for example a protein 
and a lipid bilayer imposes a particular attention to select the appropriate force fields to 
describes correctly the properties of each component of the system and the reciprocal 
interactions. 
An obvious solution to simulate a multicomponent biomolecular system is to use a force 
field containing the parameters for describing all the molecules or biomolecules of the 
system.  
Currently CHARMM is the only force field that offers the possibility of simulating all 
types of biomolecules (proteins, nucleic acids, sugars and lipids) but has two main 
limitations: a) it is an all-atoms force field, b) in the simulation of lipid bilayers it is 
necessary to use a high value of surface tension (or to use a fixed area) to obtain reasonable 
areas per lipids
73
.  
The alternative approach of combining two force fields to describes the different parts of 
the system requires considerable care. Some studies used the combination of all-atoms 
OPLS force field for the protein and of the Berger force field (derived from OPLS) for the 
lipid bilayer to simulate membrane proteins
74
, ion channels
75
 and membranes composed of 
glycolipids and phospholipids
76
. The reason for this choice is that the Berger force field, 
                                                 
70 Berger O. et al. Biophys. J., 1997, 72, 2002 
71 Jorgensen W. L. et al. J. Am. Chem. Soc., 1988, 110, 1657 
72 Tieleman D. P. et al. Condens. Matter, 2006, 18, S1221 
73 Sonne J. et al. Biophys. J., 2007, 92, 4157 
74 Bjelkmar P. et al. PloS Computational Biology, 2009, 5, 1000289 
75 Chakrabarti N. et al.Biophysical Journal, 2010, 98, 784 
76 Kapla, J. et al. J. Phys. Chem. B, 2012, 116, 244 
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derived from OPLS, reproduces the properties of a lipid bilayer with a low computational 
cost and allows a consistent treatment of the van der Waals interactions if combined with 
the OPLS-AA force field. 
Boundary conditions 
The simulation of a real molecular system by a model that considers only a limited number 
of molecules involves the correct treatment of boundary effects for obtaining the 
macroscopic properties of the system. If we consider a solute embedded in a box of water 
molecules of appropriate size, the water molecules on the edge of the box will suffer the 
result of different forces compared with the molecules inside the box. In a model system, 
where the size of the system is reduced with respect to the real system this effect becomes 
relevant. In order to minimize the effects at the edges of a finite system, it is possible to use 
periodic conditions. Therefore, the simulated system (solute and solvent) is placed in a 
cubic box or any geometric shape that is able to fill the entire space (hexagonal prism, 
truncated octahedron, elongated dodecahedron), the box is then surrounded by identical 
images of the box itself obtained by translation, along the axis x, y, z, of a quantity equal to 
the length of the box side. The two-dimensional case of this operation is shown in Figure 
4.3. The interactions considered in the simulation are those of the particles of the central 
box with all the first neighboring particles. In the case of the black atom i in the central box  
we will consider the interactions with the atoms located within the circle defined by the 
cutoff radius (Rc) (approximation of the Minimum Image). In order to avoid artifacts in the 
simulation the cutoff radius must not be larger then the half of the box side (l/2>Rc), sothat 
the i atom will interact with the j atom and not with its periodic image j'.  
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Rc
i
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Figure 4.3. Representation of a two-dimensional 
cubic box. The circle around the black dot 
represents the minimum image in which the black 
particle interacts with only the particles that are 
located within the circle of radius Rc. From: van 
Gustern  et al. Angew. Chem. Int. Ed. Engl, 
1990,29, 992  
 
The choice of the box geometry (cubic, rectangular, truncated octahedron etc) is related to 
the molecule geometry; for example, in the case of a globular protein  a truncated 
octahedral box can be chosen because this can be better approximated to a spherical 
geometry compared to a cubic geometry; in this way it is possible to reduce the number of 
solvent molecules involved in the simulation and consequently the simulation time. 
Integration of Newton's equation of motion  
Molecular dynamics simulates the time evolution of a finite system of particles through the 
integration of Newton's equations of motion. The integration of these second order 
differential equations is made by numerical methods since there is no analytical solution. 
The algorithms used to integrate the Newton’s equations differ according to i) their 
calculation accuracy (order of the algorithm), ii) size of computer memory and iii) the type 
of representation.  
The algorithms use a Taylor expansion for the quantities related to the position and 
velocity of each particle that composes the system. In these algorithms developments up to 
third order are typically used because those of the second order provide inaccurate results 
and those of higher order require large computational resources and long calculation times. 
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The Verlet algorithm is the most frequently used: the position and the acceleration of a 
particle at time t+ t are calculated from the positions and accelerations at time t- t and tby 
equations 4.5 and 4.6. 
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The sum of equation 4.5  and  4.6 equation gives equation 4.7. 
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In equation 4.7, Fi (t) is the force acting on the particle i at time t. The terms higher than 
the fourth order are neglected in the series expansion. The velocities do not explicitly 
appear in the algorithm of Verlet, in fact they are calculated from the position of the 
particles at time t+ t and t- t (equation 4.8). 
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The magnitude of the error on the velocity is t
3
. 
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The choice of integration algorithm is done on the basis of different considerations; i) the 
algorithm should involve only an evaluation of the interactions between the components of 
the system for each integration step, ii) the choice of the order of the algorithm depends on 
the type of model chosen.iii) the form of the algorithm, iv) computing resources and 
memory. In integrating the equations of motion a fundamental parameter is the step of 
integration (time-step), which is chosen at least an order of magnitude lower compared to 
the fastest motion of atoms in the simulated system. This fact represents a limit, especially 
if in the system there are high frequency motions, which are usually negligible and of little 
interest (such as the vibrations of bonds involving hydrogen atoms) with respect to the 
motion of the entire system. A solution to this limitation can be "freezing" such high-
frequency vibrational motions by using proper constraints on bond lengths that are 
maintained to their equilibrium value in the course of the simulation. In this way it is 
possible to use longer integration time steps that allow carrying out longer simulations of 
the system, thus allowing the study of motions such as the folding of proteins that occur on 
time scales of tenths of nanoseconds. 
Control of the temperature and pressure in molecular dynamics simulations 
In the integration of the equations of motion, the energy of the system is conserved and the 
system finds itself in adiabatic conditions. If the simulation is also carried out at constant 
volume the simulated system will generate a microcanonical ensemble with constant 
number of particles, volume and energy (N, V, E). The microcanonical ensemble is not 
suitable to reproduce the experimental data since these are usually obtained at constant 
pressure and temperature One of the methods for controlling the temperature in a 
molecular dynamics simulation is the weak coupling with a thermal bath
77
, this method 
was used in the simulations performed for this thesis. One of the merits of this method is 
its simplicity. The algorithm simulates the coupling of the system with an external thermal 
bath at the temperature T0. The bath acts as a source of thermal energy and the temperature 
is maintained constant to the reference value (T0) through a rescale of the velocities of the 
atoms. The deviation of the system temperature from T0 is corrected according to equation 
4.9. 
 
                                                 
77 Berendsen H. J. C. et al. J. Chem. Phys., 1984, 81, 3684 
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The result is an exponential decay of the system temperature to the reference temperature 
with a time constant . The time constant  represents the magnitude of the coupling 
between the heat bath and the system; if  is large the coupling will be weak and the 
temperature will reach slowly the reference value. If  is small the coupling will be strong 
with a fast decay of the temperature to T0. 
The change of temperature between subsequent steps is given by equation 4.10. 
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and the scaling factor for the velocities is given by equation 4.11. 
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The value that is usually chosen for the coupling constant with the thermal bath is a few 
hundred fs when the time period of integration is 1 fs. The control of pressure is obtained 
by using a method similar to that of weak coupling with a thermal bath used for the control 
of temperature. The equations are modified so that the net result of the system relaxation is 
a first order pressure to a predetermined value P0 (equation 4.12).  
 
  
p
PPP (t)
dt
(t)d 0  4.12 
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To keep the system pressure to the reference value P0, the volume of the box that encloses 
the investigated system is scaled by a factor which is equivalent to scaling the atomic 
coordinates ri by a 
1/3 
factor. The factor  is given by equation 4.13: 
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And the new position of each atom will be given by equation 4.14: 
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The value of the coupling constant, p , should be small enough (this is equivalent to a 
strong coupling) to obtain the equilibrium value of the pressure, and at the same time large 
enough (weak coupling) to avoid perturbation of the system properties.  
 
Methods  
Force Field 
The approach of combining two force fields to describes the different parts of the system 
composed of ConA and a lipid bilayer of DMPC and GA 1 or 4 was used in this work. In 
particular the combination of OPLS- AA force field for the protein and of the Berger force 
field (derived from OPLS) were used.  
The GAs 1 and 4 were considered as built by four molecular portions as shown in Figure 
4.4 for the GA 1. 
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Figure 4.4. Structure of GA 1 sezioned in four portions for parametrization by force fields. 
 
The glucose residue that interact with the binding site of the ConA was described with the 
OPLS-AA force filed for carbohydrates
78
, the trioxyethylenic residue was described with 
the OPLS
79
 united-atom force field and the region of the ammonuim group and alkyl chain 
was described with the Berger force field. In the case of the triazole moiety, absent as a 
residue in the standard force fields, the Berger nonbonding parameters were used whereas 
the bonding parameters and the partial atomic charges were obtained by ab initio 
calculations as described below. 
 
Force Field Parameters for the triazole moiety 
The force field parameters for the triazole moiety were calculated by using the 1-ethyl-4-
(methoxymethyl)-1H-1,2,3-triazole and 1-(2-methoxyethyl)-4-(methoxymethyl)-1H-1,2,3-
triazole as models to reproduce the neighbour groups linked to triazole ring in GAs 1 and 
4. The quantum mechanical calculations were performed by using GAUSSIAN03
80
 
program package whereas the molecular mechanics calculations were performed by using 
GROMACS
81
 simulation package. The partial atomic charges of the triazole were 
evaluated using the RESP
82,83
 fit method of the electrostatic potential obtained from the 
HF/6-31G(d) wave function using the Merz-Singh-Kollman scheme
84,85
. The electrostatic 
potential was calculated on the B3LYP/6-31 G(d,p) optimized geometry of the 1-ethyl-4-
(methoxymethyl)-1H-1,2,3-triazole by using a high point density around the molecule (17 
points/Å
2
 and 10 layers around the van der Waals molecular surface). The RESP fit of the 
                                                 
78 Damm W. et al. J. Comp. Chem., 1997, 18, 1955 
79 Hezaveh S. et al. J. Chem. Phys., 2011, 135, 164501 
80 Frisch M. J. et al. Gaussian 03, Revision C.02. Gaussian, Inc.: Wallingford CT, 2004  
81 Hess B. et al. J. Chem. Theory Comp., 2008, 4, 435 
82 Bayly, C. I. et al. J. Phys. Chem., 1993, 97, 10269 
83 Cornell W. D. et al. J. Am. Chem. Soc., 1993, 115, 9620 
84 Singh, U. C. et al.  J. Comp. Chem., 1984, 5, 129 
85 Besler B. H. et al. J. Comp. Chem., 1990, 11, 431 
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electrostatic potential was performed by using the antechamber tool of AMBER software 
package
86
. In order to extract the RESP atomic charges for the triazole ring, the atomic 
charges of the methoxymethyl and ethyl fragments were constrained at the value reported 
in the OPLS force field for carbohydrates
78
 and dimethoxyethane
79
 respectively. Figure 4.5 
shows the partial atomic charges obtained from the RESP fit. 
 
Figure 4.5. Partial atomic charges obtained from the 
RESP fit of electrostatic potential of 1-ethyl-4-
(methoxymethyl)-1H-1,2,3-triazole. The atomic charges 
constrained to the value reported in the OPLS force field 
are reported in italics. 
 
The bonding parameters of triazole moiety were obtained by the GROMOS96 force field
87
. 
The torsional parameters for the dihedral angles C-O-C-C, O-C-C-C and N-C-C-O between 
the triazole ring and the methoxymethyl and methoxyethyl groups were obtained by 
Density Functional Theroy (DFT) calculations. All of these dihedral angles were described 
by using the Ryckaert-Bellemans potential. The Cn parameter of the Ryckaert-Bellemans 
potential, reported in Table 4.1, were obtained by fitting the torsional profile calculated at 
the B3LYP/6-31 G(d,p) level of theory. 
 
Table 4.1. Force Field parameters for the torsional angle obtained by the Ryckaert-
Bellemans equation V(f)= [Cn(cos(φ)
n
] 
 
Torsional Angle Cn (n=0, 1,2..5) 
C-O-C-C 3.9130, 25.6431, 11.5944, -38.8938, -7.1775, 11.0126 
O-C-C-C -4.3735, -4.2109, 2.4316, 2.7585, 1.3785, 0.887 
N-C-C-O 2.1255, 26.3373, -0.6412, -33.3946, 2.3117, 3.3173 
 
                                                 
86 Case D.A. et al. 2006, AMBER 9, University of California, San Francisco. 
87 Parameters obtained from the Automated Topology Builder (ATB) and Repository version 1.2 web site 
(http://compbio.biosci.uq.edu.au/atb/) relative to Alanine-Triazole-Propionic acid. 
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Figure 4.6 shows the torsional profiles of the potential energy obtained by quantum 
mechanical calculations and by molecular mechanics calculation using the parametrized 
dihedral angles. 
 
  
Figure 4.6.: Torsional energy profiles for the dihedral C-O-C-C, O-C-C-C and N-C-C-O of 1-(2-
methoxyethyl)-4-(methoxymethyl)-1H-1,2,3-triazole. The points represent the values obtained by 
DFT calculations whereas the lines represent the values obtained by molecular mechanics 
calculation using the parametrized dihedral angle. 
 
Topology of GAs 1 and 4 
The topologies of GAs 1 and 4, that contains all the bonding and non-bonding parameters 
to described the molecules, were created according to the GROMACS rules
88
 combining 
the OPLS and the Berger force fields. 
The half-e double-pairlist method
85 
was used to ensure proper scaling of the 1-4 
interactions, between atoms separated by three bonds, when the Berger and OPLS-AA 
force fields are combined in the GROMACS package. 
In the topology of  GA 1 and 4 the 1-4 nonbonding interactions, relative to glycosydic 
bond, were scaled using two different procedures. In GA 1, characterized by the presence 
of a single methylene between the glucose residue and the triazole ring (Figure 4.7), the 1-
4 interaction for C8-C1, C7-OR and C7-C2 were scaled according to the OPLS-AA model, 
whereas a scaling based on the half-e double-pairlist method was applied to O1H-C9 and 
O1H-N13. 
                                                 
88 van der Spoel, D. et al. Gromacs User Manual version 4.5.4, 2010 
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Figure 4.7. Structure of GAs 1 and 4. The atoms of the glycosydic link and the triazole ring are 
labelled according to the symbols used in the molecular topologies. 
 
In GA 4 the 1-4 interaction for C45-C1, C7-OR and C7-C2 were scaled according to the 
OPLS-AA model, whereas a scaling based on the half-e double-pairlist method was 
applied to O1h-O46. 
 
Docking 
The structures of GAs 1 and 4 optimized by the parameterization described above were 
docked to the structure of Con A elucidated by X-rays (PDB code 3D4K
32
) by Autodock 
(v.4.2). Though Con A is a tetrameric protein, in the computational study only Chain A of 
ConA, that contains 237 aminoacidic residue and Mn 238 and Ca 239 ions that are 
structurally significant, was considered in order to reduce the size of the system. Water 
molecules were excluded from the protein for the docking study. A Lamarckian genetic 
search algorithm was used to identify low energy binding sites and orientations of the 
glycolipids. Pre-calculated atom affinities, electrostatics and solubilities were computed on 
a grid box by Autogrid (v.4.2). The box was centered at the center of the putative binding 
cavity, its dimensions were 12.6 nm x 12.6 nm x 12.6 nm. A point grid with a 0.0475 nm 
spacing nm was used. Point grid Gasteiger atom charges were assigned to the protein and 
ligand atoms using AutoDockTools. 100 randomly seeded runs were performed for 10 
runs, with an intial population of 150 individuals, and 25 milion maximum number of 
evaluations. Binding modes were ranked by an empirical force-field based scoring function 
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implemented in Autodock. The Rate of Gene mutation and Crossover of the Genetic 
Algorithm was set to 0.02 and 0.8 respectively. 1000 total simualtions were performed 
Molecular Dynamic Simulations 
System Build up 
The initial 95:5 and 90:10 DMPC/GA(1 or 4) systems were built by replacing the proper 
number of DMPC molecules with the same number of glycolipid molecules in a DMPC 
bilayer using Web Lab package. The initial DMPC/GA/Con A configurations in this study 
were built by superimposition of the GA/Con A structures, selected from the preliminary 
docking study, on the DMPC/GA bilayer by using the Membrane package of VMD (Visual 
molecular dynamics)
89
. From this procedure two structures were selected for each GA: 
structures A and B for GA 1 and C and D for the GA 4. This operation was done by 
superimposing only the sugar residue of the glycolipid in the system from the docking 
procedure to sugar residues in the DMPC/GA bilayer to find the optimal matching. The 
system was subsequently solvated with SPC (Simple Point Charge) water molecules
90
. The 
tree negative charges of the protein were neutralized with Na
+
 ions and the positive charges 
of the glycolipid with Br
-
 ions. The initial DMPC/Con A system (i.e. in the absence of 
glycolipid) was assembled by placing the protein in the same position of the A 
DMPC/1/Con A system. The box dimension for each system was 6.5 x 6.5 x 14 nm. 
Molecular Simulations 
All MD simulations were carried out with GROMACS v.4.6.1.  
Titratable residues of proteins were modelled according to their protonation state in water 
at pH = 7.  
The Mn
2+ 91
and Ca
2+ 92
 ions, included in the protein structure, and Na
+ 92
 and Br
- 93 
ions 
were treated by using the OPLS-AA parameters. 
Lennard-Jones and electrostatic interactions were calculated using a cut-off of 1.2 nm and 
the long-range electrostatic interactions were evaluated by using the particle mesh Ewald 
method (PME)
94
.  
                                                 
89 Humphrey W. et al. J. Mol. Graph., 1996. 14, 27 
90 Berendsen H. J. C. et al., Interaction models for water in relation to protein hydration. In: Intermolecular 
Forces. Pullman B, ed. Dordrecht, The Netherlands: D. Reidel Publishing Company. 1981, 331 
91 Ghitti M. et al. Angew. Chem. Int. Ed., 2012, 51, 7702  
92 Aqvist J. et al J. Phys. Chem., 1990, 94, 8021 
93 Lybrand T.P. et al.J. Am. Chem., Soc., 1985, 107, 7793 
94 Essman U. et al. J. Chem. Phys., 1995, 103, 8577 
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All bonds were constrained using the LINCS
95
 algorithm whereas the geometry of water 
molecules was fixed by the SETTLE
96
 algorithm. The simulations were carried out with a 
time step of 2 fs. The temperature of protein, lipids, water and ions was kept constant 
separately at 323 K using the Berendsen thermostat
97
 with a time constant of 0.1 ps. The 
pressure was controlled using the Berendsen barostat
97
 (P = 1 bar, τp = 1.0 ps). Pressure 
coupling was applied semiisotropically: the z and the x-y (isotropic) box dimensions were 
allowed to vary independently. Periodic boundary conditions were applied in the three 
dimensions. The systems were energy minimized and run for 10 ps at constant volume 
with a weak positional restraints on heavy atoms of protein and lipids, followed by 10 ps at 
constant pressure. Finally the systems were equilibrated with 10 ns of unrestrained MD in 
the NPT ensemble. Production runs were performed without restraints; 50 ns simulations 
were performed in the case of the DMPC/1 and DMPC/4 systems and 70 ns simulations 
were performed in the case of the DMPC/1/ConA, DMPC/4/ConA and DMPC/ConA 
systems Details on the simulated systems are summarized in Table 4.2. 
 
Table 4.2. Features of the simulated lipid bilayer systems and corresponding simulation times. 
 
System 
composition 
DMPC 
molecules 
Glycolipid 
molecules 
Con A 
Water 
molecules 
Time of 
simulation (ns) 
DMPC/1  95:5 116 6 - 13728 60 
DMPC/1  90:10 116 12 - 13574 60 
DMPC/4  95:5 116 6 - 13939 60 
DMPC/4  90:10 116 12 - 13682 60 
DMPC/Con A 116 - 1 13587 80 
DMPC/1/Con A 
A 
116 6 1 13587 80 
DMPC/1/Con A 
B 
116 6 1 13230 80 
DMPC/4/Con A 
C 
116 6 1 13055 80 
DMPC/4/Con A 
D 
116 6 1 13092 80 
                                                 
95
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Results and discussion 
Docking 
In this docking study the interaction of a single molecule of GA (1 or 4) with the Con A, 
was simulated. The goal of the docking study was to identifying the binding site of the GA 
with the protein. The hydrophobic chain of GA was not considered to reduce the 
computational cost, and the docking was centered on the protein. 10 runs of docking were 
performed and, as known, from each run 100 configurations were obtained (total 1000). 
The obtained 1000 configurations were first visualized all together as shown in Figure 4.8 
to have an idea of the regions of interaction, then only the structures characterized by the 
lowest energy (Figure 4.9) were considered. The results confirmed that the binding site is 
close to Ca
2+ 
and Mn
2+ 
ions, as reported in the literature
32
.  
 
Figure 4.8. Visualization of the 1000 results 
of the docking procedure on Con A/4 
system. 
 
 
Figure 4.9. Visualization of the lowest energy 
configurations obtained by the docking of Con A/4 
system. Ca
2+
 and Mn
2+
 ions inthe binding site of 
protein are represented as green balls. 
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Molecular Dynamics simulations  
Simulation of the DMPC/1 and  DMPC/4 systems 
The aim of these simulations was to investigate the influence of the different hydrophilic 
spacer on the exposure of the sugar residue of the GA embedded in a DMPC bilayer to the 
bulk. The build up of the DMPC/GA systems was done by the WebLab program with the 
inclusion of the 6 GA molecule in a DMPC bilayer. The systems were simulated for 60 ns 
and some relevant distances informative on the exposure of the sugar residue into the bulk 
analyzed from the trajectories by the VMD program. 
In particular, the distances between the quaternary nitrogen (N25) and the closer nitrogen 
of the triazolic ring (N11) in the case of both GAs and the distances between N25 and 
glucosidic oxygen (O1H) and N11 and O1H in the case of the GA 4 (Figure 4.10) were 
analyzed. The results relative to the O1H–N11 for both 95:5 and 90:10 DMPC/4 systems 
are reported in Figure 4.11.  
 
 
 
4 
1 
O1H N11 N25 
O1H            N11 N25 
Figure 4.11. Analysis of O1H-N11 distances for the 95:5 and 90:10 DMPC/4 systems. 
Histograms report the probability distribution of distances calculated over the trajectory. 
Figure 4.10. Visualization of the GA atoms considered in the distance analysis.  
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Histograms in Figure 4.11 report the probability distribution of distances calculated over 
the trajectory. Samples of the possible configurations characterized by certain distances are 
reported in Figure 4.12. Large distribution of distances were observed for both systems 
with a peak at 14 Å, thus suggesting that this segment of the GA is elongated, as shown in 
Figure 4.13 for the 14 Å value. Note that the other two values correspond to folded 
configurations of the polyoxaethilenic segment.The results relative to the O1H–N25 
distances, for the 95:5 and 90:10 DMPC/4 systems are reported in Figure 4.13, and 
samples of the possible configurations characterized by certain O1H-N25 distances are 
reported in Figure 4.14. Also in this case large distributions were observed with a peak at 8 
Å in the case of the 95:5 system and 12 Å in the case of the 90:10 system. As suggested by 
Figure 4.14 a value ~12 Å for the O1H-N25 distance involves a folded hydrophilic spacer. 
 
 
 
 
Figure 4.12. Three different configurations of the 
GA 4 embedded in the DMPC bilayer. For each 
configuration the O1H-N11 distance is indicated.  
Figure 4.13. Analysis of O1H-N25 distances for the 95:5 and 90:10 DMPC/4 
systems. Histograms report the probability distribution of distances calculated over 
the trajectory. 
Å Å 
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The results relative to the N25-N11 distance, for the 95:5 and 90:10 DMPC/4 and DMPC/1 
systems are reported in Figure 4.16. All the probability distributions observed in Figure 
4.15 are very large with two peaks for shorts and long distances in each of the reported 
histograms. The large distribution and the presence of two peaks both indicate a high 
variability of the N25-N11 distance and a high mobility of the first portion of the 
hydrophilic spacer (i.e. the portion close to the lipid/water interface). Figure 4.16 shows 
samples of GA 4 featuring the N25-N11 distances corresponding to the probability 
distribution peak in the histograms in Figure 4.15.  
Even if the DMPC/1 (4) 90:10 analysis didn’t put in evidence a destabilization of these 
systems, in analogy with the experimental part there were considered only the DMPC/1 (4) 
95:5 fort the interaction with the ConA. 
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Figure 4.15. Analysis of N25-N11 distances for the 95:5 and 90:10 DMPC/1 and 
DMPC/4 systems. Histograms report the probability distribution of distances 
calculated over the trajectory. 
Figure 4.16. Two different configurations of the 
GA 4 embedded in the DMPC bilayer. For each 
configuration the N25-N11 distance is 
indicated.  
   
Å Å 
Å Å 
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Simulations of the DMPC/GA/ConA systems 
The simulations of the selected A, B, C and D DMPC/GA/ConA systems were aimed at 
investigating the interactions of ConA with DMPC bilayers characterized by the presence 
of the different GA 1 or 4 and comparing them with the system in the absence of GA, i.e. 
DMPC/ConA system. The five lipid/ConA systems were built up and simulated for 80 ns 
and the parameters that characterize the five lipid/protein systems were analyzed over the 
trajectories. In particular the following parameters were investigated after a qualitative 
analysis of the evolution of the binding site and of aminoacidic residues involved in the 
binding: 
- The Area/lipid parameter 
- The root mean square deviation (RMSD) of the protein that evaluates the position of its 
atoms with respect to starting coordinates. 
- The distance between the protein and the lipid bilayer 
- The number of H-bond between the protein and DMPC molecules 
- The number of H-bond between the protein and glycolipid molecules. 
Assembling of lipid/ConA systems   
The five lipid/ConA systems were assembled as explained in the experimental part, by 
matching the sugar residue of GA in the lowest energy structures obtained by docking with 
the sugar residues of GAs in the corresponding minimized 95:5 system. The best matching 
was made visually by VMD by selecting only the DMPC/1/ConA and DMPC/4/ConA 
configurations that did not shows contacts or overlaps of ConA with DMPC/1 and 
DMPC/4 systems. Figure 4.17 shows two explicative examples, that is a configuration with 
a high DMPC/ConA overlapping, (left) that was not suitable as a starting configuration for 
the simulation and a configuration where the protein is close to the lipid bilayer without 
touching it (right) that was suitable for simulation. Figure 4.18 reports the four initial 
configurations selected for the DMPC/1/ConA system, i.e. configurations A and B and for 
the DMPC/4/ConA system, i.e. configurations C and D. The reference DMPC/ConA 
system was built by removing the 6 GA molecules from system A. 
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Figure 4.17. Two configurations of the DMPC/4/ConA system. The left panel shows a 
configuration characterized by high extent of overlapping between Con A and DMPC (not 
suitable as a starting configuration for simulation). Right panel shows a configuration where the 
protein is close to the lipid bilayer without ConA-DMPC overlappings (suitable as a starting 
configuration for simulation). DMPC is drawn in green, red and blue, GA is drawn in white. 
 
 
 
Figure 4.18. Starting configurations of DMPC/1/Con A (A and B), and DMPC/4/Con A   
(C and D).  
 
Conf. A Conf. B 
Conf. C Conf. D 
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Qualitative analysis of the evolution of the binding site and of aminoacid residues of Con A 
involved in the binding with GA 
The aim of this qualitative analysis was having an overview of the position of the protein 
and the GAs, during the simulation, and to identify the aminoacid residues and the regions 
of GA involved in the Con A-GA binding. Figures 4.19-4.22 show the evolution of the 
binding site during the simulation for the A, B, C, D systems, snapshots of the systems at 
t=0 and at certain interesting times during the trajectory are reported. For each snapshot the 
aminoacid residues involved in the interaction with the GA were identified considering a 
cut off of 0.35 nm, the same used in the H-bonds analysis reported in one of the next 
sessions.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19. Evolution of the binding site during the simulation of the A system and 
aminoacid residues involved in the binding with GA. 
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Figure 4.20. Evolution of the binding site during the simulation of B system and aminoacid 
residues involved in the binding with GA. 
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Figure 4.21. Evolution of the binding site during the simulation of C system and aminoacid 
residues involved in the binding with GAs. 
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It can be observed that: 
- In the four cases the aminoacidic residues involved in the binding with the sugar residue 
are in general the same as those given by the X-ray analysis
32
, i.e. Arg 228 in A system, 
(Figure 4.19), Tyr 100 in B system (Figure 4.19), Asp 218 in D system (Figure 4.2), or in 
any case very close to them such as  Ser 201 or Thr 15 in C system (Figure 4.20). 
- The binding site does not change over the simulation, in fact the aminoacids involved in 
the binding are the same or located in the binding site as demonstrated by the residue 
numbering. 
- In the case of both the DMPC/1/ConA system (A and B) only one GA is involved in 
binding with ConA. In the case of the C system the starting configuration that involves two 
GAs in the binding with the protein changes during the simulation into configurations 
Figure 4.22. Evolution of the binding site during the simulation of D system and 
aminoacidic residues involved in the binding with GAs. 
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involving only one GA in the binding. On the other hand two GAs are constantly involved 
during the simulation of the D system  in the binding with the protein. 
The A/lipid parameter 
The A/lipid parameter, (equation 4.15) where A is the area of the face box, and lipid is the 
number of DMPC of one of the two considered layers, i.e. 58 for these systems, simulates 
the headgroup lipid area. This is a parameter that can be obtained also experimentally and 
the comparison of the experimental and theoretical value of the A/lipid ratio allows 
estimating tha reliability of the model used in simulation. In this work the headgroup area 
was not measured experimentally however it was analyzed over the trajectory.  
                                 A/Lipid= xy/58                                               4.15 
Figures 4.23-4.25 show how the A/Lipid parameter changes over the trajectory in the 
DMPC/ConA (Figure 4.23), in the A and B systems (Figure 4.24) and in the C and D 
systems (Figure 4.25). The analysis indicates that in the the DMPC/ConA and in the two 
DMPC/1/ConA systems the A/Lipid parameter does not change during the trajectory thus 
indicating a good reliability of the model. On the other hand, in both the DMPC/4/ConA 
systems the A/Lipid parameter fluctuates periodically during the trajectory. The variability 
of the A/lipid parameter implies that there is a fluctuation on the z axis so that the system 
reacts by changing xy to keep the volume constant. The variability observed is unusual 
because the headgroup surface should not change over the trajectory, moreover the model 
used, with the exception of GA molecules. is the same of that used for the  A and B 
systems. The periodic fluctuation observed in the cases of C and D systems has probably to 
be ascribed to artifacts due to the use of the Berendsen barostat. The Berendsen thermostat 
and barostat do not strictly provide a correct NPT ensemble, but is very useful, because 
efficient and rapid, to obtain structural an dynamic properties of the system. The version of 
GROMACS 4.6.1 contains an implementation of this barostat that can give artefacts. In the 
development of the work it will be necessary to change barostat and use, for example, the 
Parinello-Rahman barostat
98
 which yelds a correct NPT ensemble.  
                                                 
98
 Parinello M. J. et al. Appl. Phys., 1981, 52, 7182 
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Figure 4.24. Plots of A/Lipid parameter versus the time of the simulation (ps) for the A 
and B systems.  
Figure 4.25. Plots of A/Lipid parameter versus the time of the simulation (ps) for the C and D 
systems.  
  
Figure 4.23. Plots of A/Lipid parameter versus the time 
of the simulation (ps) for the DMPC/ConA system. 
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RMSD parameter of ConA 
The root mean square deviation (RMSD) of certain atoms in a system with respect to a 
reference structure can be calculated with the program g_rms by least-square fitting the 
structure to the reference structure at time 0 (t2=0) and subsequently calculating the RMSD 
(equation 4.16)99,  
                                                                                               
 
                                                                                                                                       4.16 
 
where M= ∑ 
N
 m
i 
is the total mass of the system and ri (t) is the position of atom i at time t.  
In this case RMSD evaluates the position of the atoms of the protein with respect to the 
starting configuration that corresponds to its structure obtained by X-ray, (PDB 3D4K
32
). 
The computation of RMSD is a way to check when the system reaches the equilibrium. 
Figures 4.26-4.28 report the RMSD for the DMPC/ConA and A, B, C, D systems during 
the trajectory. The RMSD analysis indicates that the protein reaches a good conformational 
stability after 10 ns of simulation. Therefore 70000 ps (70 ns) were considered as effective 
time of production for all the simulated systems in all the analysis.  
 
 
 
 
 
                                                 
99
 User gromacs manual version 4.0 from www.gromacs.org 
Figure 4.26. Plot of RMSD of 
DMPC/ConA  systems versus time of 
simulation (ps). 
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Figure 4.27. Plot of RMSD of A and B systems versus time of simulation (ps). 
Figure 4.28.  Plot of RMSD of C and D systems versus time of simulation (ps). 
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Protein-lipid bilayer distance 
In order to study the distance and orientation of the protein with respect to the lipid bilayer 
the distance between the mass center of the protein and the DMPC bilayer was analyzed. 
This analysis can give an idea of the interactions of the protein with the lipid bilayer, these 
can be stronger or weaker with respect to the initial configuration. This analysis was 
carried out by using the g_dist program (i.e. GROMACS). Figures 4.29-4.31 show the 
plots of the protein-lipid bilayer distance versus the time of simulation. According to the 
RMSD of the protein, only the production time will be considered (i.e. since time=10ns). 
In the case of DMPC/1/ConA  systems, the distance of the protein from the lipid bilayer 
increases (from ~2.7 to ~3 nm) in system A and remains constant (at ~3 nm) in system B; 
note that in the DMPC/ConA system (Figure 4.29) the distance does not vary ( ~2.7 nm). 
On the other hand, the presence of GA 4 has an attractive effect toward the protein during 
the simulation in both the C and D investigated systems (from ~3 to ~2.7 nm). In the case 
of the DMPC/4/ConA system in the starting configuration the protein is set at a larger 
distance due to the longer hydrophilic spacer however during the simulation the folding of 
the spacer induce a descrease of the ConA-lipid bilayer distance to the same value (~2.7) 
observed in the DMPC/ConA system.  
 
 
 
 
 
Figure 4.29.Variations of the protein –
DMPC lipid bilayer distance in the 
DMPC/ConA system. 
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Figure 4.31 Variations of the protein –DMPC lipid bilayer distance in the C and D 
systems. 
 
Figure 4.30. Variations of the protein –DMPC lipid bilayer distance in the A and B 
systems. 
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Number of protein-DMPC H-bonds  
The interaction between ConA and the lipid bilayers can be mediated by the hydrophobic 
interaction, dipolar  interactions and H-bonds depending on the position of the protein with 
respect to the lipid bilayer. This analysis was carried out by using the g_hbond program 
(i.e. GROMACS) with a cutoff of 0.35 nm. If the protein interacts with the surface of the 
lipid bilayers H-bonds between the phosphate group and carbonyl groups of DMPC and 
some aminoacidic residues of the protein might have a very relevant role in the attraction 
and stabilization of the protein. Figures 4.32-4.34 report the variation of the number of H-
bonds between the protein and DMPC molecules during the simulation. The number of H-
bonds in the DMPC/ConA system was ~ 6 in the initial configuration and was maintained 
as such during the simulation. The presence of GA 1 involved a number of 6-9 H-bonds 
though in a part of the trajectory of the B configuration the number decreased. On the other 
hand, the presence of the GA 4 in the DMPC bilayer involves a higher number of H-bonds, 
i.e. 9-12. This result can be due to the different orientation of the protein with respect to the 
lipid bilayer mediated by the GAs. In the case of the DMPC/4/ConA systems theGA 4 
molecules induce a higher extent of contact surface, as indicated by the larger number of 
protein-DMPC H-bonds. 
 
 
Figure 4.32. Plots of the number of DMPC-
ConA H-bonds versus the time of the simulation 
(ps) for the DMPC/Con A system. 
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Figure 4.33. Plots of the number of DMPC-ConA H-bonds versus the time of the simulation (ps) 
for the A and B systems 
Figure 4.34. Plots of the number of DMPC-ConA H-bonds versus the time of the simulation (ps) 
for the C and D systems. 
Number of protein/glycolipid H-bonds 
The analysis of the number of H-bonds occurring between the protein and glycolipid 1 and 
4 is reported in the plots shown in Figures 4.35 and 4.36. In the case of DMPC/1/ConA 
systems the initial configuration influences the number of H-bonds of the protein with GA 
1 occurring during the simulation. In the first configuration (A) the number of H-bonds set 
to 2 in the initial configuration remains constant for all the trajectory, this is in agreement 
with what observed in the qualitative analysis where the GA is in contact with the same 
number of aminoacids during the simulation. On the other hand in the second configuration 
(B) the minor number of H-bond, i.e. 1, of the initial configuration involves in some phases 
of the evolution the complete loss of H-bonds, as also described in the qualitative analysis. 
In the case of the DMPC/4/ConA systems in the C configuration the number of H-bonds 
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varies between 0 and 4 during the trajectory whereas in the D configuration it varies 
between 0 and 7. The larger number of interactions depends on two main factors, as also 
shown in the qualitative analysis: first the presence of a longer hydrophilic spacer increases 
the probability of contacts; second the involvement of two GA in the binding (system D).  
 
 
 
 
 
 
Figure 4.35. Plots of the number of glycolipid - ConA H-bonds versus the time of the 
simulation (ps) for the A and B systems. 
 
Figure 4.36. Plots of the number of glycolipid - ConA H-bonds versus the time of the simulation 
(ps) for the C and D systems. 
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Conclusions  
In this work the molecular dynamic was used to study the interaction of two different GA 1 
and 4 embedded in DMPC bilayer with the Con A. In Table 4.3 the relevant results 
obtained by the analysis of the molecular dynamic simulation trajectories relative to the 
simulated systems are summarized.  
Table 4.3. Summary of relevant results obtained by the analysis of the molecular dynamic 
imulation trajectories relative to the simulated systems 
 
It is clear that the presence and the type of GA influences the interactions of ConA with the 
DMPC bilayer. In particular the major length of the hydrophilic spacer in GA 4 mediates a 
higher number of hydrogen bonds thus contributing to a better binding with the protein.  
 Simulated systems 
Investigated 
parameters 
DMPC/Con
A 
A B C D 
H-bonds 
DMPC-Con A 
6 7 7 10 10 
H-bonds 
GA-ConA 
- 2 1-2 3-4 5-7 
Distance (nm) 
DMPC-ConA 
~2.7 ~3 ~3 ~2.5 ~2.7 
98 
 
Concluding remarks 
 
In this thesis the synthetic possibility of creating a library of glycosylated amphiphiles was 
explored. It was shown that the adopted synthetic procedures allow modulating fairly easily 
the hydrophobic region, the sugar residue and the hydrophilic spacer of an ammonium salt 
scaffold. In view of the inclusion of the glycolipids in lectin targeting liposomes, it was 
considered that the length of the hydrophilic spacer might be a crucial parameter for 
controlling both the exposure of the sugar moiety on the surface of liposomes and its 
mobility for the interactions with the lectins. Therefore GA 1 and GA 4 characterized by the 
same hydrophobic region and the same sugar residue (glucose) but by a different 
hydrophilic spacer were compared for what concern their interaction with concanavalin A 
(ConA), a glucose specific plant lectin. 
The interaction of lipid bilayers composed of a natural phospholipid (DMPC) and GA 1 or 
GA 4 with the protein were investigated by both an experimental and a theoretical approach. 
 
 
The experimental investigation showed that the displacement of glycogen from the binding 
sites of the protein occurred in the presence of a lower concentration of GA1 with respect to 
Ga4 thus indicating a better capability of the glucose moiety of GA1 to interact with the 
binding sites of the protein. At the monomeric level this is probably due to a coiled 
conformation of GA4 that might hinder a good exposure of the sugar moiety with respect to 
GA1. However, when included in lipid bilayers the behavior of the two glycosylated 
amphiphiles is different. Infact the results of agglutination experiments showed that GA 4 
containing liposomes interact with the lectin better than GA 1 containing liposomes. The 
turbidity experiments showed that the addition of ConA to suspensions of DMPC/1 and 
DMPC/4 liposomes induced a modest increase and a relevant increase of optical density, 
GA 4 
GA 1 
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respectively as shown in Figure 1 (circle symbols). Further, in the case of DMPC/4 
liposome precipitation was observed at ~ 100 minutes. The DLS experiments reported in 
Figure 1 (triangle symbols), confirmed the turbidity experiment results showing a relevant 
increase of the size of liposomes upon addition of ConA only in the case of DMPC/4 
liposomes. Agglutination occurs according to a mechanism analogous to that described in 
Figure 2, and can be ascribed to the multivalent nature of the sugar-lectin interaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Turbidity increase (GA 4 red circles; GA 1 blue circles) and size changes  
(GA 4 red triangles; GA 1 blue triangles) observed upon the addition of Con A to a 
suspension of 95:5 DMPC/GA vesicles in PBS. Con A concentration is 0.33 
mg/mL; total lipids concentration is 0.8 mM. 
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The experimental results were nicely confirmed by the molecular dynamics simulations that 
gave an atomistic description of the interactions involved in the binding of DMPC/GA 
bilayers with ConA. The results of simulation analysis showed that the DMPC/4 bilayer 
interacts at a larger extent with the protein as demonstrated by the higher number of H-bond 
of the lipid bilayer with ConA. The higher number of H-bonds implies a larger surface of 
contact between the lectin and the lipid bilayer. The involvement of a higher extent of 
protein-lipid bilayer interaction is mediated by the interaction of ConA with two molecules 
of GA 4 instead of the single GA 1 molecule involved in the interaction of ConA with the 
DMPC/1 bilayer, Figure 3, and by a larger number of H-bond between GA 4 and the 
aminoacids of the binding site due to the longer hydrophilic spacer. Therefore both the 
experimental and theoretical approaches allowed us to identify which is the better 
hydrophilic spacer for the interaction of glycosylated liposomes with ConA among the two 
explored. 
 
 
 
Figure 2. Schematic representation of agglutination. 
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Future developments 
 
Other experiments are scheduled to confirm and clarify the results obtained in this work of 
thesis. X-ray measuraments on the explored formulations in the presence and in the absence 
of ConA will give further insights on the interactions involved. Further the other structural 
parameters of GA should be investigated to elucidate the influence of the hydrophobic 
anchor on the stability of the formulations and on their physicochemical features. For what 
concerns the sugar moiety, glucose has been investigated as a model for two main reasons: 
i) the easiness of the synthetic procedures involving glucose and ii) the easy availability of 
ConA that is a glucose specific lectin. However, human lectins are specific for galactose 
therefore in the future the sugar residues of choice will be galactose and lactose, and the 
biological evaluation will be carried out on liposomes functionalized with these sugars. 
However some cell lines express glucose receptors and a preliminary evaluation on cells 
will be carried out also exploiting DMPC/1 and DMPC/4 liposomes. 
 
 
Figure 3. Representative images  of the binding between GA1(left) and GA4 (right) the lectin 
during the simulation.  
